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Acute Coronary 
Syndrome (ACS) 
ACS is a series of conditions which include chest discomfort or 
any other symptoms caused by the decreased oxygen supply 
to the myocardium. Coronary artery disease caused by plaque 
etc. that leads to clotting in the coronary arteries and impairs 
the blood supply to the heart (American Heart Association, 
2009). 
Coronary Artery 
Bypass Graft 
Surgery (CABG; 
on-pump & off-
pump) 
Coronary artery bypass graft surgery a surgical procedure 
performed to relieve angina and to reduce the risk of death 
from coronary artery disease. Veins are harvested from the leg 
and grafted to the diseased coronary artery to restore 
coronary circulation supplying the myocardium with oxygen. 
This surgery is either performed with cardiopulmonary bypass 
(on-pump) or on a beating heart (off-pump) (Sabik and Lytle, 
2008). 
Cardiopulmonary 
bypass 
A procedure to circulate and oxygenate the blood while 
surgery is performed on the heart. It involves the drainage of 
oxygen poor blood from the heart and lungs through the heart-
lung machine, and then returns oxygen rich blood to the aorta 
(Chilton and Klein, 2009). 
Cerebral Blood 
Flow 
Indicates the amount of blood that supplies the brain with 
oxygen at a given time (The Free Dictionary, 2012(b)). 
Complications 
An adverse response to a procedure or therapy 
(MedicineNet.com, 2012). 
 Chapter 1 
LIST OF DEFINITIONS 
LINDY LIEBENBERG:   MAGISTER TECHNOLOGIAE CLINICAL TECHNOLOGY 
 
XVIII 
Hemodynamics 
Hemodynamics is the study of blood flow or the circulation – 
the force involved in the circulation of blood (Merriam-Webster. 
Online Dictionary, 2012(a); Medical-Dictionary, 2012(a)). 
Hypoperfusion 
Decrease blood flow through an organ, thus there is also a 
decrease in oxygen delivery. If hypoperfusion is prolonged it 
may result in cellular dysfunction and death (Merriam-Webster 
Online Dictionary, 2012(b)). 
Mini-Mental State 
Examination 
A brief psychological test designed to differentiate among 
dementia, psychosis, and affective disorders. It may include 
ability to count backward by 7s from 100, to identify common 
objects such as a pencil and a watch, to write a sentence, to 
spell simple words backward, and to demonstrate orientation 
by identifying the day, month, and year, as well as town and 
country (Medical-Dictionary, 2012(c)). 
Near Infrared 
Spectroscopy 
Near infrared spectroscopy (NIRS), is a non-invasive, optical 
method for the in vivo monitoring of tissue oxygenation 
(Chakravarti, Srivastava and Mittnacht, 2008). 
  
Outcomes 
The condition of a patient at the end of therapy or a disease 
process, including the degree of wellness and the need for 
continuing care, medication, support, counseling, or 
education (Medical-Dictionary, 2012(b)). 
Oxygenation 
Oxygenation is the amount of oxygen in blood, it describes the 
hemoglobin oxygen-carrying capacity (The Free Dictionary, 
2012(a)). 
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Die doel van hierdie studie was om ondersoek in te stel of die intra-operatiewe 
serebrale weefsel suurstof saturasie en hemodynamise monitering van pasiënte met 
akute koronêre sindroom tydens koronêre vat omleiding (KVO) chirurgie, kliniese 
uitkomste en komplikasies kan voorspel. 
 
Data van 60 KVO pasiënte (30 met behulp van die hart-long apparaat en 30 sonder 
die hulp van die hart-long apparaat) is ontleed. Die plaaslike serebrale weefsel 
suurstof saturasie is gemonitor deur gebruik te maak van naby-infrarooi 
spektroskopie (NIRS). Twee Somasensors word in die middel van die pasiënt se 
voorkop geplaas en die kabels word dan gekonnekteer aan die sensors en aan die 
Somanetics INVOS 5100C® Oximeter. Volgens die NIRS waardes, is pasiënte in twee 
groepe verdeel. Pasiënte in Groep 1 het absolute NIRS waardes van meer as 50 of 
minder as 20% daling vanaf die basislyn. Pasiënte in Groep 2 het die absolute NIRS 
waardes van minder as 50 of 'n daling van meer as 20% van die basislyn. Die laagste 
waarde aangeteken tydens die prosedure is vir hierdie doel aangeteken. Die intra-
operatiewe hemodinamiese monitering is opgeneem deur 'n rekenaar program 
(verskaffer, Datex Ohmeda, Suid Africa). 
 
Om chirurgiese uitkomste te beoordeel is verskeie parameters ontleed en vergelyk. 
Dit sluit 'n pre-en post-operatiewe Mini-Mental staat toets wat uitgevoer is om 
neurologiese uitkomste te identifiseer. Die NIRS waardes en tendense met betrekking 
tot nierfunksie (U & E en kreatinien, urine, en urine elektroliete), sowel as kliniese 
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uitkomste is post-operatief in die verskillende groepe ontleed. Kliniese uitkomste is 
beskryf met behulp van die Vereniging van Thoraks Chirurge se Databank (STS 
databasis) data velde, en spesifiek die opname van komplikasies. 
 
Die uitkomste tussen die pomp (met hart-long apparaat) en geen pomp (sonder 
hart-long apparaat) KVO groepe sowel as hul NIRS resultate is ontleed. Om die 
voorspellende rol van NIRS te bepaal, is die pasiënte in groepe verdeel met of 
verswakte / verminder NIRS waardes of aanvaarbaar NIRS waardes gebasseer op 
gepubliseerde resultate waar 'n vermindering van meer as 20% van die basislyn of 
absolute waardes van minder as 50 gepaardgaande was met slegter kliniese 
uitkomste.  
 
Ten slotte is die voorspellende waarde van NIRS geëvalueer binne die pomp en dan 
die  geen pomp KVO groepe. In hierdie analise is die uitkomste van pasiënte met 
verminderde NIRS waardes vergelyk met dié van pasiënte met aanvaarbare NIRS 
waardes. 
 
Die studie het getoon dat die meerderheid van die pasiënte met verminderde 
serebrale vloei / suurstof lewering, soos weerspieël in serebrale NIRS, het pomp KVO 
prosedures gehad (84% het in risiko groep 2 geval). Dit het ook getoon dat NIRS 
vermindering van meer as 20% vanaf die basislyn en waardes van minder as 50, 'n 
impak het op die post-operatiewe nierfunksie. 
 
Monitering van serebrale oximetrie intra-operatief deur van NIRS gebruik te maak 
tydens hartchirurgie (veral in die pomp kardiale chirurgie pasiënte) stel die perfusie 
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tegnoloog en narkotiseur in staat om serebrale desaturasie te noteer en daarop te 
reageer in 'n poging om die kliniese uitkoms te verbeter. 
Dit is waarskynlik belangrik om in 'n verdere ondersoek te kyk na die tyd wat 
spandeer word wanneer die NIRS waarde onder 50 val of tydens 'n daling van meer 
as 20% van die basislyn.  Dit is belangrik om vas te stel of die "area onder die kurwe" 
as' n spesifieke faktor vir verhoogde risiko vir post-operatiewe komplikasies 
betekenisvol is op 'n vergrote studiepopulasie. 
 
Die studie ondersteun die roetine gebruik van NIRS as 'n tendens monitor van 
serebrale saturasie.  Die gebruik daarvan het beide die perfusie tegnoloog en 
narkotiseer attend gemaak op serebrale perfusie, intervensie is toegepas waar 
nodig wat gelei het tot uitstekende kliniese uitkomste in hierdie reeks. 
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The objective of this study was to investigate whether intra-operative regional 
cerebral tissue oxygen saturation (NIRS) and hemodynamic monitoring in patients 
with Acute Coronary syndrome (ACS) during coronary bypass graft surgery (CABG 
on-pump vs. off-pump) can predict clinical outcomes and complications.  
 
Data from 60 CABG patients (30 on-pump and 30 off-pump) were analyzed. The 
regional cerebral tissue oxygen saturation was monitored by using near-infrared 
spectroscopy (NIRS). The sensors were positioned in the middle of the patient's 
forehead and the cables were connected to the sensors and to the INVOS 5100C® 
Oximeter. According to NIRS values obtained, patients were subdivided into two 
groups. Patients in Group 1 had absolute NIRS values more than 50 or less than a 20% 
drop from the baseline value.  Patients in Group 2 had absolute NIRS values of less 
than 50 or a drop of more than 20% from the baseline value. The lowest value 
recorded during the procedure was recorded for this purpose, irrespective of the 
time this value was obtained. Intra-operative hemodynamic monitoring was 
captured by a computer software program (Supplier Datex Ohmeda, South Africa). 
 
In order to describe surgical outcomes several parameters were analysed and 
compared. This included a Pre- and Post-operative Mini-Mental state examination 
that was performed to identify neurological outcomes or impairment. The NIRS 
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values and trends in relation to renal function (U&E and creatinine, urine output, and 
urine electrolytes), as well as clinical outcomes were analyzed post-operatively for 
the different groups.  Clinical outcomes were described using the Society of 
Thoracic Surgeons Database (STS database) data fields, and specifically the 
recording of complications. 
 
The overall clinical outcomes were analysed between the on-pump and off-pump 
groups as well as the NIRS results between the two groups. 
 
In order to elucidate the predictive role of NIRS the patients were divided into groups 
with either impaired /reduced NIRS values or acceptable NIRS values according to 
published results where a reduction of more than 20% from baseline or absolute 
values of less than 50 were associated with inferior outcomes. 
 
Finally, the predictive value of NIRS was evaluated within the on- and then the off-
pump groups. In this analysis the outcomes of patients with reduced NIRS values was 
compared to those of patients with acceptable NIRS values. 
 
The study demonstrated that by far the majority of patients with reduced cerebral 
flow/oxygen delivery as reflected in cerebral NIRS, had on-pump CABG procedures 
(84% fell in risk group 2). It also showed that a NIRS reduction of more than 20 % from 
baseline and values of less than 50, has an impact on post–operative renal function.   
 
Monitoring of cerebral oximetry intra-operatively by using near-infrared spectroscopy 
during cardiac surgery (especially in on-pump cardiac surgery patients) allows the 
perfusionist and anaesthesiologist to detect cerebral desaturation and to intervene 
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as necessary. This study also showed a tendency towards less renal function 
impairment in patients with absolute NIRS values > 50 or where there was < 20% drop 
from baseline.  
 
It is probably important to consider studying the time spend below 50 or a drop of 
more than 20% from baseline NIRS values, or the “area under the curve” as a 
specific factor contributing to the increased risk for post-operative complications 
applied on an increased study population. 
 
The study supports the routine use of NIRS as a non-invasive trend monitor of cerebral 
saturation and certainly initiated interventions by both anaesthetic and perfusion 
staff which contributed to excellent clinical outcomes in this research study. 
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Acute Coronary Syndrome (ACS) refers to a range of acute myocardial ischemic 
states that occurs after the sudden blockage of a coronary artery. This may cause a 
reduction in blood supply to certain areas of the myocardium and results in ischemia 
(Warnica, 2008). Treatments for ACS includes medical treatment, percutaneous 
coronary intervention (PCI), and coronary artery bypass grafting (CABG) with or 
without the use of cardiopulmonary bypass (CPB). 
 
Cardiac surgery and anaesthetic techniques have improved over the years, but 
Central Nervous System (CNS) dysfunction continues to be a major cause of 
morbidity after cardiac surgery (Fun-Sun, Chia-Chih, Chee-Yueh, Serle and Powel, 
2004). Cerebral micro-embolism and hypoperfusion have been proposed to be 
major mechanisms of dysfunction, where low perfusion pressure and re-warming 
during CPB may cause an imbalance between oxygen supply and demand. In both 
mechanisms, tissue hypoxia is the common pathway causing cerebral dysfunction 
(Fun-Sun et al., 2004). 
 
Performing CABG without cardiopulmonary bypass (off-pump CAB) has shown to 
reduce the risk of peri-operative stroke. Whether off-pump CAB (OPCAB) reduces 
the incidence of less severe neurocognitive impairment has not yet been clearly 
established (Scarborough, White, Derilus, Mathew, Newman and Landolfo, 2003). 
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Heart manipulation during OPCAB can impair cardiac output and induce 
hypotension, which can result in significant brain hypoperfusion (Berry, McGarvey, 
Zeng and Woo, 2005). 
 
Greater focus is being put on neuro-protective strategies to improve quality of life.  
Various neurological complications remain prevalent, but regional ischemia leading 
to adverse outcomes is detectable and correctable and a variety of parameters 
have been used traditionally to guide the question of whether oxygen supply is 
meeting oxygen demand at tissue level.  Blood pressure, pulse oximetry (SpO2) 
central venous oximetry (SvO2), arterial blood gasses and serial lactates are a few 
examples of these parameters. 
 
The Somanetics® INVOS® Cerebral Oximeter (Covidien) augments these existing 
strategies by providing a new “vital sign” called regional saturation of oxygen (rSO2).  
The system alerts clinicians of cerebral ischemia and proved an early warning for 
regional oxygen imbalances that may be encountered in surgery or in the cardiac 
laboratory. 
 
The aim of this study is to predict the incidences of complications and clinical 
outcomes in patients with acute coronary syndrome related to reduced cerebral 
perfusion. Observations with near-infrared spectroscopy will be done during on-
pump and off-pump CABG to measure cerebral oxygenation, and will be related to 
hemodynamic changes and intra−operative manipulation. 
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 2.1 ACUTE CORONARY SYNDROME (ACS) 
 
2.1.1 Definition 
 
The term Acute Coronary Syndrome (ACS) refers to a range of acute myocardial 
ischemic states after the sudden blockage of a coronary artery. This may cause a 
reduction in blood supply to certain areas of the myocardium resulting in ischemia. 
ACS encompasses unstable angina, non-ST segment elevation myocardial infarction 
(ST segment elevation generally absent), and ST segment elevation infarction 
[persistent ST segment elevation usually present, (Warnica, 2008)]. 
 
2.1.2 Treatment 
 
Therapy for acute coronary syndrome includes medical treatment (e.g. Aspirin, 
Clopidogril, Nitoglycerin and ACE Inhibitors), Percutaneous Coronary Intervention 
(PCI, which is a revascularization therapy that avoids the need for bypass), and 
Coronary Artery Bypass Grafts (CABG) with or without the use of cardiopulmonary 
bypass [Figure 2.1; (Warnica, 2008)]. 
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Figure 2.1 Summary of the Treatment options available for Acute Coronary  
  Syndrome (ACS) 
   [PCI = Percutaneous Coronary Intervention; CABG = Coronary Artery Bypass Grafting] 
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2.1.2.1 Medical Treatment 
 
The treatment for ACS can be achieved through the administration of 
pharmacological drugs (Table 2.1) thus without the use of interventions such as PCI 
or CABG. 
 
Table 2.1 Pharmacological drugs used in the treatment of ACS (adapted from: 
Heart and Stroke Information point, 2010). 
 
DRUG MODE OF ACTION 
Aspirin An antiplatelet drug used in all patients with coronary artery disease. 
Clopidogrel 
Is also an antiplatelet drug that is used with aspirin or in patients who 
cannot tolerate aspirin alone. 
Calcium channel blockers 
Relaxes the arteries and lowers blood pressure, resulting in a 
decrease in workload of the heart. 
ACE inhibitors 
Also reduces workload of the heart by relaxing the arteries and 
lowering blood pressure. This drug also reduces the risk of a heart 
attack and stroke. 
Angiotensin Receptor blockers 
This drug is an effective alternative for patients who cannot tolerate 
ACE inhibitors. 
Statins 
A cholesterol lowering drug that is given to the patient, even if the 
patient‟s cholesterol levels are normal, to reduce the risk of a heart 
attack. 
Beta-Blockers 
Is a drug for long-term use, and is prescribed for patients with 
unstable angina or patients with any sign of heart muscle damage. 
Eplereone 
This drug is an aldosterone receptor antagonist and is prescribed to 
patients who had a heart attack and have diabetes. 
Nitrates 
It dilates the blood vessels, resulting in a decrease in the workload of 
the heart. 
Anticoagulants 
For long-term use in patients with ACS to reduce the risk of systemic 
emboli. 
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2.1.2.2 Percutaneous Coronary Intervention (PCI) 
 
Percutaneous Coronary Intervention (PCI) is a non-invasive way to treat diseased 
arteries. The procedure is performed by inserting a balloon catheter into the femoral 
artery in the groin area, through the blood vessels, and then to the blocked artery of 
the heart. The balloon is then dilated to open the vessel, which sometimes may 
include a metal tube called a stent. Although PCI is non-invasive there is always „n 
risk of needing another intervention later on in life (Torpy, Lynm and Glass, 2004). 
 
2.1.2.3 Coronary Artery Bypass Graft (CABG) Surgery 
 
Coronary Artery Bypass Grafting (CABG) was introduced in the 1960s and is 
effectively used for the relief of angina and the stabilization of ventricular function.  
Since then CABG was established as a safe and effective operation worldwide 
(Livesey, 2006).  Just as a detour on the highway in case of a roadblock, CABG 
involves the strategic placement of bypass grafts that will act as an alternative route 
for blood flow to bypass blockage (Shekar, 2006). 
 
For the purpose of this study emphasis will be place on CABG surgery as the 
treatment method of choice for patients diagnosed with ACS. 
 
Currently, there are two different ways in which surgeons perform CABG surgery, the 
traditional way with the use of cardiopulmonary bypass (CPB) which is called on-
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pump CABG and the latest approach which is without the use of CPB which is called 
off-pump CABG. 
 
2.1.2.3.1 On-pump Cardiopulmonary Artery Bypass Graft 
(CABG) Surgery 
 
Cardiopulmonary bypass (CPB) is a technique that temporarily takes over the 
function of the heart and lungs during surgery via a heart-lung machine, to maintain 
the circulation of blood and the oxygen content of the body.  
 
In short, during on-pump CABG, saphenous veins are harvested from the patient's 
leg, and if need be the radial artery is dissected from the forearm. These veins are 
grafted to the coronary arteries to bypass atherosclerotic narrowing. The chest is 
opened via a median sternotomy and a cannula is placed in the right atrium to 
withdraw blood from the body into an oxygenator where gas exchange takes 
place. The cannula that is used to return oxygenated blood is inserted into the upper 
ascending aorta. The patient is then taken onto bypass, cooled down and 
cardioplegia is administered to stop the heart (Livesey, 2006).  
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2.1.2.3.2 Off-pump Cardiopulmonary Artery Bypass Graft 
(CABG) surgery 
 
Off-pump CABG, also known as OPCAB, is very similar to the conventional on-pump 
CABG procedure. OPCAB still utilizes a medial sternotomy, however the important 
difference is that the cardiopulmonary bypass pump is not used, and the surgery 
takes place on a beating heart. With the heart still beating, there is a greater 
difficulty in performing a bypass on the posterior and lateral walls of the heart. The 
surgeon manipulates the heart to the necessary position and uses a stabilizer to 
expose the site where the anastomoses must be performed (Livesey, 2006). 
 
 2.2 COMPLICATIONS ASSOCIATED WITH CORONARY ARTERY 
BYPASS GRAFT (CABG) SURGERY 
 
CABG is considered as one of the landmark operations in the history of cardiac 
surgery that rescued millions of people diagnosed with coronary artery disease 
(Shekar, 2006).  However, this breakthrough operation was not without complications 
and adverse events.  Some of the complications associated with CABG was 
systemic inflammatory response, cerebral dysfunction, myocardial depression and 
hemodynamic instability (Shroyer, Grover, Hattler, Collins, McDonald, Kozora, Lucke, 
Baltz and Novitzky, 2009).  CABG may be successful in the revascularization of the 
heart but the surgical procedure may have adverse effects on the brain (Zangrillo, 
Crescenzi, Landoni, Leoni, Marino, Calabrò, Corno, Pappalardo and Alfieri, 2005). 
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Neurological abnormalities surpassed mortality as the primary distinguishing feature 
of cardiac surgery.  Nearly half a million adult patients worldwide are annually 
affected by neurologic disability related to CABG.  The mechanisms of injury 
implicated include reperfusion, inflammatory, excitotoxic, compromised cerebral 
blood flow, ischemic and embolic events (Hoffman, 2006). 
 
The frequent occurrence of ischemic episodes during CABG has been linked to 
transient and permanent neurocognitive impairment, brain abnormalities, and bio-
chemical and histopathologic signs of injury (Hoffman, 2006).  Age also contributes 
to the incidence of cerebral complications after cardiac surgery.  For instance the 
incidence of stroke after CABG is less than 1% in patients under the age of 64 years 
but 5% in patients aged 65 to 75 years and 7-9% in patients older than 75 years (Tan, 
2008).   
 
The neurological damage encountered after cardiac surgery is divided in type I 
(focal injury, stupor, or coma at discharge) and type II [deterioration in intellectual 
function, memory deficit, or seizures; (Zangrillo et al., 2005)].  Neurocognitive decline 
(intelligence, problem solving, concentration, learning, memory, error free 
performance and dexterity) occurs more frequently than stoke with 60% at 1 week 
after surgery, and 25 to 30% between 2 months and 1 year (Tan, 2008). 
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2.2.1 Neurological dysfunction and Cardiopulmonary Artery 
Bypass Graft (CABG) surgery 
 
The incidence of neurocognitive disorders increase with the use of total circulatory 
arrest and hypothermia (Tabaee, Rostami, Arefi and Sadeghi, 2009).  However, brain 
injury following CABG is usually attributed to two main causes: embolization 
(macro/micro) and compromised cerebral blood flow (Tan, 2008). 
 
2.2.1.1 Compromised Cerebral Blood Flow (on-pump and off-
pump) 
 
The brain is the most vulnerable organ that can be affected by a complete lack of 
blood supply. However, should the blood flow through the brain be compromised, it 
may be tolerated briefly by an increase in oxygen extraction from available blood 
flow. The amount of cerebral blood flow depends mainly on carbon dioxide (CO2) 
tension in the cerebral tissue. The cerebral vessels will dilate due to a decrease in 
oxygen tension. Administration of anaesthetics may reduce brain metabolism as 
much as 40%, which will cause a partial decrease in cerebral blood flow (Reed and 
Anderson, 1986). 
 
Under conditions that often pertain in adults undergoing cardiac operations, 
cerebral blood flow is about 25 ml.min-¹.m-² (normal cerebral blood flow range from 
45–50 mL.min-¹.100g-¹) brain tissue with some variability depending on PaCO2 
(Govier, Reeves, McKay, Karp, Zorn, Morawetz, Smith, Adams and Freeman,1984). 
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During normothermic and moderately hypothermic CPB in adults, cerebral blood 
flow is not significantly altered with variations of mean arterial blood pressure 
(Brusino, Reves, Smith, Prough, Stump and McIntyre, 1989). This is similar to situations 
in a normal awake human adult, in whom cerebral blood flow does not vary 
significantly with variations of mean arterial blood pressure (from about 
60 to 150 mmHg). When arterial blood pressure during CPB falls below 40 mmHg, 
cerebral blood flow may decline appreciably, with a decrease in oxygen 
consumption (Feddersen, Aren, Nilsson and Radegran, 1986). 
 
Therefore, a decrease in CPB flow rate has an effect on cerebral blood flow, 
because there is a direct correlation between CPB flow rate and cerebral blood 
flow, despite the poor correlation between arterial blood pressure and cerebral 
blood flow. Soma and co-workers (1989) performed a study on two groups; one was 
a hypotensive group and the other group “normal”. They concluded that mean 
arterial pressure had no significant influence on cerebral blood flow during CPB, in 
other words cerebral blood flow is CPB flow rate dependant (Soma, Hirotani, Yozu, 
Onoguchi, Misumi, Kawada and Inoue, 1989). 
 
Cerebral blood flow during CPB is also affected by PaCO2. Hypercarbia increase 
cerebral blood flow, whereas hypocarbia decrease cerebral blood flow (Govier, 
1984). Under usual conditions of CPB, the metabolic needs of the brain are met with 
a PaCO2 of 33 mmHg (Kern, Ungerleider, Quill, Baldwin, White, Greeley and Reves, 
1991). 
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Cerebral blood flow during CPB may at times be excessive in relation to cerebral 
oxygen consumption. During CPB, the patient‟s body temperature is reduced from 
37ºC to 28ºC; in which cerebral blood flow decrease less than cerebral oxygen 
consumption (Croughwell, Newmann, Blumenthal, White, Lewis, Frasco, Smith, 
Thyrum, Herwits and Leone, 1994). 
 
A major complication following cardiac surgery is cerebral injury. Off-pump CABG 
(OPCAB) has become popular over the years since CPB is associated with 
neurologic dysfunction. Although, there are several reports in favour of OPCAB, 
beneficial effects of OPCAB on cerebral function are still controversial (Kim, Kwak, 
Oh, Kim, Yoo and Hong, 2005). Manipulation of the heart during OPCAB to expose 
the graft site induces hemodynamic instability, and could compromise cerebral 
perfusion (Murkin, Kaplan, Reich, Konstadt and Saunders, 2000). The effect of 
hemodynamic derangement occurring during positioning of the heart on cerebral 
perfusion is however, not known, for example: 
 
 Steep Trendelenburg position to the expose posterior side of the heart 
elevates the jugular venous pressure, compromising cerebrospinal fluid (CBF) 
independent of an acceptable mean arterial pressure [MAP; (Kim, Kwak, Oh, 
Kim, Yoo and Hong 2005)]. 
 Decrease in cardiac output [CO; (due to arrhythmias, dislocation of the 
heart, ischemia etc.) may compromise blood flow to the brain (Kim et al., 
2005). 
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 Positioning the heart for anastomoses of the circumflex and posterior 
descending artery is a risk for inducing hypotension, impaired cardiac index 
and generalized hemodynamic instability with risk of cerebral compromise 
(Murkin et al., 2000). 
 
 Compromised right ventricular diastolic filling as a result of direct ventricular 
compression may be the primary mechanism for producing hemodynamic 
instability during OPCAB surgery (Murkin et al., 2000). 
 
 Embolic events may also occur due to the placement of the partial occlusion 
aortic clamp to perform proximal graft anastomoses, because arteriosclerotic 
plaque may detach and end up in the systemic circulation (Nierich, Diephuis, 
Jansen, Borst and Knape, 2000). 
 
(a) Microcirculation 
 
The microcirculation is the part of the systemic and pulmonary circulation 
responsible for the exchange of water, gases, nutrients and waste material. The 
microcirculation includes arterioles, capillaries, venules, and terminal lymphatic 
vessels (De Backer, 2005). 
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Features of the microcirculation differ from that of the systemic circulation: 
 
 Capillary PO2 is much lower than arterial PO2. 
 Local hematocrit differs from systemic hematocrit. 
 Microcirculatory blood flow control is complex and depends on both local 
metabolic control and systemic humoral control. 
 Microvessels differ among organs, for that reason some organs may be more 
vulnerable to a decrease in global blood flow (De Backer, 2005). 
 
Keeping this in mind CPB affects the microcirculation of a patient in the following 
ways: 
 
 The tone of the arterioles and capillary walls are affected – regulation of 
vascular resistance change with alterations in temperature. 
 
 Leucocytes were activated and adhere to vascular endothelium under 
conditions of cardiopulmonary bypass (Wagner, Schiller, Dilg, Depner, Welz and 
Lacour-Gayet, 2001). 
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Comparing exposure to normothermic and hypothermic CPB, it was found that the 
temperature of perfusion has no effect on microcirculation during non-pulsatile CPB 
(Wagner et al., 2001). 
 
However, de Jaegere and Suyer (2002) stated that non-pulsatile flow produced by 
CPB have an adverse effect on the microcirculation, resulting in arteriolar shunting 
and post-operative organ dysfunction/failure. 
 
(b) Brain Temperature and regional Oxygen Saturation (rSO2) 
 
Temperature has an important effect on tissue oxygenation. Standard temperature 
monitoring during CPB may not accurately characterize the efficacy of cerebral 
cooling (Hogue, Sundt, Goldberg, Barner and Davila-Roman, 1999). 
 
Hypothermia reduces the solubility of gases, such as CO2, in blood. Thus, at lower 
systemic temperatures, the PaCO2 is relatively low, resulting in an elevated pH with 
alkalosis. The higher pH causes the oxyhemoglobin dissociation curve to shift to the 
left, which result in: 
 
 Decrease oxygen availability to the brain tissue and 
 Cerebral vasoconstriction – leading to a reduced cerebral blood flow (Hogue 
et al., 1999). 
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There are two acid-base strategies during hypothermic CPB: 
 
i) pH stat 
 
 Which restore PaCO2 and pH to normal non-hypothermic levels. 
 In pH stat CBF is relatively high, but pressure-flow auto regulation is lost. 
 
ii) Alpha stat 
 
 PaCO2 is allowed to be relatively low and the pH is allowed to remain high. 
 CBF is reduced but pressure-flow auto regulation is still maintained so that 
the reduced CBF is met with a decrease in cerebral metabolic rate (Hogue 
et al., 1999). 
 
Although there is a lack of evidence to support the option to use alpha-stat or pH-
stat management, as to which is more beneficial to brain protection, temperature 
reduction by means of extracorporeal circulation with alpha-stat acid-base 
management result in a decrease in cerebral blood flow and a decline in metabolic 
rate (Greeley et al., 1989). Predicted flow should ensure adequate cerebral 
oxygenation during cooling. However, other variables are also involved in the 
maintenance of adequate tissue oxygenation, for instance rSO2 varied inversely with 
cooling rate (Daubeney, Pilkington, Janke, Charlton, Smith and Webber, 1996). 
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Hypothermia (33-35°C) during cardiopulmonary bypass definitely has 
neuroprotective benefits and evidence suggest that hypothermic improves 
neurologic outcome even when induced after a cerebral ischemic event 
(Nussmeier, 2005).  
 
However, the rate and extend of re-warming from hypothermic CPB can promote 
neurologic injury. Several studies have shown that rapid rates of re-warming after 
hypothermic CPB resulted in reduced jugular venous oxygen saturation, presumably 
a result of increased cerebral metabolism and elevated oxygen extraction levels 
within the cerebral circulation (Cook, Oliver, Orszulak and Daly, 1994). Grigore and 
co-workers (2002) have linked rapid re-warming rates and cerebral hyperthermia to 
post-operative neurocognitive decline (Grigore, Grocott, Mathew, Philip-Bute, 
Stanley, Butler, Landolfo, Reves, Blumenthal and Newman, 2002). 
 
In summary a reduced arterial blood pressure during CPB contributes to post-
operative neurological dysfunction, because hypotension resulted in reduced 
cerebral blood flow (Branthwaite, 1974). When cerebral blood flow was measured 
during operations involving hypothermia, it was observed that patients with an 
increased oxygen extraction before hypothermia may be more vulnerable to 
cerebral injury. During cooling a reduction in cerebral oxygen consumption and 
cerebral blood flow occurred. Other studies have confirmed the observation that 
cerebral blood flow generally decrease with temperature during cooling, and that 
the link with cerebral metabolism is maintained even with low temperatures when 
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ventilation is managed according to the alpha-stat strategy (Greeley, Kern, 
Underleider, Boyed, Quill, Smith, Baldwin and Reves, 1991).  
 
In a healthy normothermic brain, cerebral blood flow and metabolism is tightly 
linked. Vital neuronal function may be maintained during flow reduction of up to 
50% by increasing oxygen extraction. During re-warming there is often a result of 
desaturation, as the temperature induced an increase in cerebral metabolism, 
which is usually not linked to augmentation of brain perfusion. Daubeney et al., 
(1996) again described a relationship between rSO2 and nasopharyngeal 
temperature during re-warming. 
 
2.2.1.2 Embolization (on-pump and off-pump CABG) 
 
As previously stated one of the main causes for neurocognitive impairment during 
CPB is embolization.  This includes both macromolecules (macroembolization) and 
microparticles (microembolization).  Macroemboli occludes vessels larger than 200 
µm and are possibly related to massive air embolisms, usually due to human error or 
set-up defaults in the CPB circuit (Baufreton, 2010).  Embolisms of particles or thrombi 
that become detached from aortic plaques during aortic operative manipulation 
can also cause these occlusions (Scarborough et al., 2003). 
 
On the other hand microemboli occludes small vessels, arterioles and capillaries (10 
to 70 µm) with neurological manifestations that are usually only detected by 
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specialized neuropsychological tests to confirm neurocognitive decline 
(Scarborough et al., 2003). Microembolization (50% of patients when detected 
systematically) occur much more frequent than macroembolization [about 10 times 
fewer; (Roach, Kanchuger, Magano, Newman, Nussmeier, Wolman, Aggarwal, 
Marschall, Graham, Ley, Ozanne and Mangano, 1996)].  Microemboli can also result 
from cardiac activities such as de-airing, circulating lipid particles or platelet 
aggregates to numerous particles associated with surgery itself like glove talcum 
powder or it can originate from the CPB circuit (Baufreton, 2010). 
 
Microemboli are also distributed in proportion to blood flow.  Alpha-stat acid-base 
management and phenylephrine during CPB reduce cerebral injury by causing 
cerebral vasoconstriction and reducing the number of microemboli. Also, major 
changes in CBF occur with changes from pulsatile to non-pulsatile flow with the 
initiation of cardiopulmonary bypass (Edmonds et al., 2004).  However, low perfusion 
pressure and related changes in cerebral blood flow during CPB affect the 
clearance and destination of embolic particles.  The clearance of microemboli from 
the brain is probably impeded by a decreased flow in patients with a lower mean 
arterial pressure (MAP) which leads to lower cerebral perfusion and ultimately 
cerebral injury (Tan, 2008).  Anaemia and elevated cerebral temperatures increase 
cerebral blood flow but may cause inadequate oxygen delivery to the brain 
(Edmonds et al., 2004). 
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Cerebral blood flow increases with temperature: brain injury associated with 
normothermic and hyperthermic CPB are more likely due to increase cerebral 
microemboli, which produce large lesions at higher cerebral temperatures. 
 
 Brain temperature = important neuroprotective strategy that is protective 
against neural cell necrosis (Edmonds et al., 2004). 
 
Murkin and co-workers (2002) has demonstrated that although higher MAP is a 
requirement for cerebral well-being during CPB, cerebral venous hypertension might 
be a potential contributor to cerebral dysfunction. They described that dislocation 
of the heart in the presence of a single, two-stage venous cannula during CPB, may 
occlude the superior vena cava and result in jugular venous hypertension. This give 
rise to inadequate cerebral perfusion pressure, despite “normal” MAP, resulting in 
cerebral venous hypertension and decrease cerebral blood flow (Murkin, Boyd, 
Ganapathy, Adams, Peterson, Morgan and Lok, 2002).  
Keeping the complications associated with CPB (intense systemic response, systemic 
and pulmonary capillary leak and pulmonary, renal and neurocognitive 
dysfunction) in mind CABG is now possible without the use of CPB (Ascione, Lloyd, 
Underwood, Lotto, Pitsis and Angelini, 2000). 
 
It is believed that off-pump surgery reduce postoperative morbidity, including 
reduced myocardial injury, renal dysfunction, neurocognitive deficit, and SIRS.  
However, off-pump cardiac surgery still results in tissue trauma, cardiac 
manipulation, pericardial suctioning and the administration of exogenous drugs such 
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as heparin, protamine and many anaesthetic agents. Therefore, a physiological 
stress response with resulting increases in pro-inflammatory markers still exist.  The 
magnitude of the response, however, is significantly less than that observed when 
using CPB (Ascione et al., 2000). 
 
Research shows that OPCAB should improve neurologic outcome due to both a 
reduction in cerebral emboli generation as well as avoidance of prolonged periods 
of cerebral hypoperfusion.  However, several investigators have failed to 
demonstrate an improvement in cognitive function following CABG (Hernandez, 
Cohn, Baribeau, Tryzelaar, Charlesworth, Clough, Klemperer, Morton, Westbrook, 
Olmstead, O‟Conner, Mack, Grover and Hasan, 2001). Some found no difference in 
cognitive function in patients after OPCAB or CABG with CPB. Hernandez and 
colleagues (2001) have found that the post−operative stroke rate after OPCAB 
(1.33%) was not significantly different from that after CABG with CPB (1.82%). Thus, 
although off-pump CABG is associated with a reduction in the number of 
intra−operative cerebral microemboli, a clear relationship between the reduction in 
microemboli and improvement in neurocognitive function remains inconclusive. 
 
Technical advances may further improve the neurological outcomes after OPCAB. 
Cardiac displacement to gain access to the posterior wall during OPCAB causes 
transient elevation in central venous pressure and simultaneously decrease systolic 
blood pressure thus producing hemodynamic instability (Nierich et al., 2000). Even 
without CPB, periods of cerebral hypoperfusion are possible during OPCAB. Embolic 
events may occur due to the placement of the partial occlusion aortic clamp to 
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perform proximal graft anastomoses. OPCAB does not entirely eliminate the 
possibility of either cerebral microembolism or cerebral hypoperfusion. 
 
Moritz, Arlt, Voelkel, Hilker and Hobbhahn (2007) has shown in a randomize study 
that positioning of the heart during OPCAB, provoke changes in cerebral oxygen 
saturation.  They concluded that an alteration in PaCO2, decrease cardiac output 
and systemic oxygen delivery, which has an effect on cerebral oxygen saturation, 
but not with changes in MAP. This means that when PaCO2 remains constant, 
changes in cerebral oxygen saturation are most likely to reflect a decrease in 
cardiac output or systemic oxygen delivery. Displacement of the heart may lead to 
systemic hypoperfusion and cerebral venous hypertension. 
 
  2.3 METHODS TO ASSESS COGNITIVE DECLINE AFTER CABG 
SURGERY 
 
Cognitive assessment is regarded as a valuable clinical skill.  Cognitive assessment is 
commonly used for the following reasons (a) screening for cognitive impairment, (b) 
differential diagnoses of cause and (c) rating the severity of the disorder or 
monitoring the disease progression(Woodford and George, 2007). 
 
Over the years a wide range of tools have been developed and used by clinicians 
to assess cognitive function.  These include screening tools that takes less than 1 
minute to complete to formal neurophsycological assessments that lasts for several 
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hours.  However, the choice of the appropriate tool depends on both the time 
available and the purpose of the assessment (Woodford and George, 2007). 
 
Some of the assessment tools that can be used includes the Abbreviated Mental 
Test (AMT), Six-Item Screener (SIS), Six-Item Cognitive Impairment Test (6CIT), Clock 
Drawing Test (CDT), Mini-Cog and the Mini Mental State Examination (MMSE).  The 
psycho-geriatricians in the United States of America, Canada and the United 
Kingdom regard MMSE as the most commonly used cognitive screening tool 
(Woodford and George, 2007).  The test generally correlates well with other 
cognitive screening test scores and reasonably well with a number of 
neuropsychological tests (Woodford and George, 2007). Many studies used the 
MMSE as one the tests to assess neurocognitive outcome in patients undergoing 
cardiac surgery (Nussmeier, Miao, Roach, Wolman, Mora-Mangano, Fox, Szekely, 
Tommasino, Schwann, Mangano, 2010). 
 
2.3.1 The Mini Mental State Examination (MMSE) 
 
Originally used to screen for Alzheimer's disease, MMSE is a brief, standardized and 
validated instrument to screen for dementia (Table 2.2).  It is used in the clinical and 
research setting and measure cognitive impairment in various disease states, 
document intellectual changes over time and assess the effects of potential 
therapeutic agents on cognitive function (Nussmeier et al., 2010). 
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The MMSE is a brief 30-point questionnaire (Figure 2.2) grouped into 7 cognitive 
domains (Lopez, Charter, Mostafavi, Nibut and Smith, 2005). It is commonly used in 
medicine to screen for dementia. In a time span of about 10 minutes, it samples 
various brain functions, including arithmetic, memory and orientation (Folstein, 
Folstein and McHugh, 1973). 
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MAXIMUM 
SCORE 
SCORE     
      ORIENTATION 
5 (     )   What is the: (year)   (season)  (date)  (day)  (month) 
5 (     )   Where are we: (state)   (county)  (town)  (facility)  (floor) 
    REGISTRATION 
3 (     ) 
  Name three objects and have person repeat them back. Give one point for each 
correct answer on the first trial.    
1. _______   2. _______   3. _______ 
Then repeat them (up to 6x) until all three are learned.   
[Number of trials ____ ] 
    ATTENTION   AND CALCULATION 
5 (     ) 
  Serial 7's.   Count backwards from 100 by serial 7's.  One point for each correct 
answer.   Stop after 5 answers.  [ 93  86  79  72  65 ] 
Alternatively spell "world" backwards.  [ D - L - R - O - W ] 
    RECALL 
3 (     ) 
  Ask for the names of the three objects learned above.  Give one point for each correct 
answer. 
    LANGUAGE 
9 (     ) 
  
Name:  a pen (1 point) and a watch (1 point) 
Repeat the following:  "No ifs, ands, or buts" (1 point) 
Follow a three-stage command:  "Take this paper in your [non-dominant] hand, fold 
it in half and put it on the floor". (3 points)  
[1 point for each part correctly performed] 
Read to self and then do: "Close your eyes" (1 point) 
Write a sentence [subject, verb and makes sense] (1 point) 
Copy design [ 5 sided geometric figure; 2 points must intersect]  
(1 point) 
Score:       /30                     Alert           Overtly Anxious            Concentration Difficulty           Drowsy 
CLOSE YOUR EYES 
 
SENTENCE 
 
Figure 2.2  Mini-Mental State Examination (adapted from Folstein et al., 1975) 
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The MMSE is performed prior to surgery to obtain a baseline value of the patient's 
current cognitive status.  The test is then repeated after the procedure and the 
results are compared with the pre-operative MMSE see whether cognitive decline 
can be confirmed.  Patients exposed to transient ischemic attacks, hypertension, 
agina and stroke which is often the case with CABG patients usually show deficits in 
short-term memory first.  They are more prone to have changes in speech and 
language function, such as naming objects and following the three-step command 
(Vertesi, Lever, Molloy, Sanderson, Tuttle, Pokoradi and Principi, 2001) 
 
Table 2.2 Deficits that can be addressed with MMSE (adapted from Vertesi et al., 
2001). 
MMSE Components 
Alzheimer's 
Disease 
Vascular 
dementia 
Dementia with 
LEWY bodies 
1-5       Orientation on time X   
6-10     Orientation to place X   
11         Repeat three objects    
12         Spelling WORLD backward   X 
13         Recall Three Objects X X X 
14, 15  Recognize objects  X  
16        Recognize idiom    
17        Close your eyes  X  
18        Copy a design  X X 
19        Write a sentence  X  
20        Three-step Command  X  
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2.3.1.1 Interpretation of MMSE scores 
 
Lopez et al., (2005) recommended the following cut-off values to assess cognitive 
ability: 
 
 ≥ 27 = normal 
 21-26 =mild  
 11-20 = moderate 
 ≤ 10 = severe. 
 
Dementia and other neurological complications can be closely correlated with low 
to very low MMSE scores.  Scores can be influenced by educational level, language 
and cultural barriers, meaning that patients with a low educational level can be 
wrongly classified as being demented and those with higher levels may be missed.  
A decline in MMSE scores are also seen in patients with advance age.  However, the 
raw score can be corrected for educational level and age (Woodford and George, 
2007). 
 
The MMSE alone cannot be used for accurate diagnosis, but data on its sensitivity 
and specificity shows the usefulness of the test as a screening instrument (Vertesi et 
al., 2001). However, "prevention is better than cure".  Due to the importance and 
frequency of cognitive decline during CABG surgery, emphasis was placed on the 
development and application of monitors to aid clinicians to enhance detection 
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and improve treatment of conditions associated with brain injury.  Oxygen is 
essential to the survival of any human being. If we can accurately assess the 
adequacy of oxygen delivery to key organs it can have a major impact on pre- and 
post-operative complications and outcomes. 
This led to the development of various brain oxygen monitoring systems in the form 
of intracranial oxygen electrodes, jugular venous saturation monitoring and various 
forms of transcranial oximetry via near-infrared spectroscopy (Hoffman, 2006). 
 
  2.4 METHODS TO ASSESS CEREBRAL OXYGEN SATURATION 
DURING CABG SURGERY 
 
German physiologist Karl von Vierordt was the first person to monitor human blood 
oxygenation in 1874.  In 1930 another German Karl Metthes first used variable 
transmission of red and infrared light through the human ear to access oxygenation.  
But it was only in 1942 that American Glenn Milliken coined the term oximeter.  This 
was followed by the development of pulse oximetry by a Japanese bioengineer 
Takuo Aoyagi in 1972 and was later modified by William New an anaesthesiologist 
for use in anaesthesia and critical care (Cohn, 2007). 
 
Greater focus is being turned to neuro-protective strategies to improve quality of life.  
Various neurological complications remain prevalent, but regional ischemia leading 
to adverse outcomes is detectable and correctable and a variety of parameters 
have been used traditionally to guide the question to whether oxygen supply is 
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meeting oxygen demand at tissue level.  Blood pressure, pulse oximetry (SpO2) 
central venous oximetry (SvO2), arterial blood gasses and serial lactate levels are a 
few examples of these parameters (Somanetics®, 2005 (a)). 
 
Non-invasive infrared monitoring of cerebral oxygenation was first demonstrated by 
Jobsis in 1977. He showed that the absorption of infrared light by the human body 
tissue was negligible and can be used to evaluate cerebral oxygenation (Zaslin and 
Chistyakov, 2006). To date there is several near-infrared spectroscopy (NIRS) 
techniques that have been developed to investigate tissue hemodynamics, and the 
majority of these techniques are based on Beer‟s law which was modified to be 
apply on live tissue (Maikala, 2010).  However, for this study emphasis will be placed 
on near-infrared spectroscopy (NIRS). 
 
2.4.1 NEAR-INFRARED SPECTROSCOPY (NIRS) 
 
Near-infrared spectroscopy is based on the Beer-Lambert Law which states that 
when light is transmitted through a solution containing a coloured compound a 
potion will be absorbed by the compound resulting in a reduced intensity of the 
emerging light [(Cohn, 2007); Figure 2.3]. 
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Figure 2.3 The Beer Lambert Law (a portion of the light is transmitted through a solution 
containing a coloured compound is absorbed by the compound, with the 
result that the intensity of the emerging light is reduced (adapted from Cohn, 
2007). 
 
In tissue, light scatters and in the microcirculation oxygenated and deoxygenated 
haemoglobin is absorbed differently (Figure 2.4).  The amount of light that returns to 
the sensor will provide a ratio of oxygenated haemoglobin to total haemoglobin 
and it will be expressed as a percentage.  When Jobsis developed non-invasive NIRS 
he observed that deoxygenated haemoglobin exhibits a weak absorption peak at 
760 nm, and oxygenated haemoglobin does not.  Based on these findings he was 
the first to suggest that NIRS might have value as a monitor of oxygen sufficiency 
(Cohn, 2007; Murkin and Arango, 2009). 
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Figure 2.4 Light absorption of haemoglobin related to its state of oxygenation.  (In 
the near-infrared range, absorption of light is different in deoxygenated 
haemoglobin when compared with oxygenated haemoglobin. These 
differences can be measured and used to differentiate the adequacy of 
haemoglobin oxygenation in blood adapted from Cohn, 2007). 
 
Another important fact to remember is that NIRS primarily assesses the haemoglobin 
saturation of venous blood, and with capillary blood, composes approximately 90% 
of the blood volume in tissues.  On the other hand pulse oximetry, uses fewer and 
different wavelengths of light, requires pulsatile flow, and targets only small 
additional arterial blood volume produced at the measurement site during systole.  
Due to these differences it is believed that NIRS reflect the oxygen saturation of 
haemoglobin in the post-extraction compartment of tissue (Cohn, 2007; Tan, 2008). 
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2.4.1.1 Somanetics® INVOS® Cerebral Oximeter 
 
The Somanetics® INVOS® Cerebral Oximeter augments these existing strategies by 
providing a new “vital sign” called regional saturation of oxygen (rSO2).  The system 
alerts clinicians of cerebral ischemia and proved an early warning of regional 
oxygen imbalances that may be encountered during surgery or in the cardiac 
laboratory (Somanetics®, 2005 (a)).  
 
The principal of auto regulation states that over a wide mean arterial pressure 
range, 50 mmHg to 150 mmHg, cerebral blood flow remains independent of 
perfusion pressure. Numerous studies have concluded that cerebral auto regulation 
remains intact during cardiac operations, both before and during CPB bypass. This 
conclusion may be correct for large groups of patients, but it does not apply to 
each individual patient (Edmonds et al., 2004).  Cerebral oximetry provides a 
method to identify lower limits of auto regulation; this is the point where cerebral 
blood flow and cerebral oxygenation becomes pressure dependant. The 
independence of mean arterial pressure (MAP) and rSO2 establishes the correct 
auto regulation during surgery for each individual patient (Figure 2.5). 
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Figure 2.5 Oximetry Defines Lower Limit of Auto regulation (Adapted from Edmonds 
et al., 2004).  The relationship between rSO2 and mean arterial pressure (MAP) during CPB is 
depicted. Each symbol represents a single-point paired measurement obtained at 5 minute intervals. 
The upper Figure illustrates intact cerebral auto regulation with clear independence of rSO2 and MAP 
over a wide pressure range. The patient‟s outcome was uneventful. In contrast, the lower Figure 
depicts de-auto-regulation with classic appearance of a vascular waterfall. Each time the MAP fell 
below 80 mm Hg, a marked rSO2 decrease occurred, indicating that cerebral perfusion pressure had 
fallen below the lower limit of auto regulation. Presumably as a result of suboptimal cerebral 
perfusion, the patient experienced a prolonged recovery complicated by delirium. 
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Two conclusions are reached: 
(i) Lower limit of auto regulation varies widely among patients – from MAP 
 <40 mmHg to >100 mmHg. 
(ii) Large portion of patients do not maintain auto regulation throughout 
 operation due to a decrease in temperature. 
 
These findings emphasize the importance of cerebral perfusion monitoring during 
cardiovascular surgery (Edmonds et al., 2004). 
 
The driving force for haemoglobin through the gas exchanging microvasculature is 
not arterial pressure but pressure differential between arterial and venous. Factors 
that increase cerebral venous pressure will compromise oxygen delivery, even if 
MAP is in normal range. It is useful to monitor the relationship between rSO2 and 
cerebral perfusion pressure (Edmonds et al., 2004). 
 
 
 
Cerebral oximetry is also a useful guide for the management of regional low flow 
perfusion (RLFP). NIRS has been used to guide bypass flow during RLFP with the 
intention to match cerebral blood volume during RLFP to baseline blood volume on 
full bypass flow to the whole body. Monitoring rSO2 will individualize titration of pump 
flow to prevent both cerebral hypoperfusion and hyperperfusion. In agreement with 
these observations, Hofer, Haizinger and Geiselseder (2002), found a linear 
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relationship between rSO2 and antegrade supplemental cerebral perfusion pump 
flow (Edmonds et al., 2004). 
 
Deeb and co-workers (1995) demonstrated that NIRS-guided retrograde cerebral 
perfusion extended the “safe time” for hypothermic circulatory arrest during aortic 
arch reconstruction. Superior vena cava cannula malpositioning is also detectable 
by cerebral oximetry during retrograde cerebral perfusion (Edmonds et al., 2004). 
 
As previously stated, renal dysfunction is a complication of cardiac surgery. A 
reduction in MAP and blood flow can result in renal hypoperfusion leading to 
ischemic injury. Andersson and co-workers (1994) showed that auto regulation of 
renal blood flow (RBF) is not operational during hypothermic CPB due to the fact 
that RBF was largely proportional to systemic blood pressure. According to the 
statistical analysis the pump flow rate was the primary determinant of RBF and that 
systemic blood pressure was of secondary importance (Andersson, Bratteby, Ekroth, 
Hallhagen, Joachimsson, Van Der Linden and Wesslen, 1994). 
 
(a) Technical Overview Somanetics® INVOS® Cerebral Oximeter 
 
The INVOS® System consists of disposable, single-patient use SomaSensors, an INVOS 
monitor display and associated accessories.  The system‟s light-emitting diodes 
generate near-infrared (NIR) wavelengths (730 – 810nm) that when applied to the 
frontal lobe of the brain for example, pass through the scalp and bone tissue 
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beneath the sensor.  Once in vivo they are either absorbed or scattered back up to 
the sensors‟ shallow and deep detectors.  Red-coloured haemoglobin molecules 
within red blood cells have the highest light absorption of the wavelengths used, 
and the exact shade of red of each haemoglobin molecule indicates the amount 
of oxygen it is carrying.  The absorption data returned to the detectors reflects 
deoxy-haemoglobin and total haemoglobin from which regional saturation of 
oxygen (rSO2) is calculated.  Application of the NIR light-emitting sensors to the brain 
thus allows for direct measurement of changes in oxygen saturation in the blood 
capillary bed below the sensor through non-invasive measurements.  Since the 
vascular bed is predominantly venous, the INVOS® System reflects the balance of 
oxygen delivery and consumption [the surplus of oxygen remaining after the tissues 
have taken what they require; (Somanetics®, 2005 (a)]. 
 
(b) Interpretation of Results 
 
A decline in rSO2 below 50, or a decline of more than 20 percent from baseline is 
cause for concern and warrants the initiation of intervention.  Absolute values below 
40 and a drop of more than 25 percent from baseline, is associated with 
neurological dysfunction and other adverse outcomes (Edmonds et al., 2004). 
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(c) sRO2 Desaturation Risk Score 
 
rSO2 is at the core of “risk score” calculation to determine cognitive decline (Slater, 
Stack, Vinod, Guarino and Bustami, 2007). The rSO2 desaturation risk score is 
calculated by multiplying the number of points below 50% rSO2 by the time in 
seconds. Patients with any combination where the rSO2 value and time resulted in 
>6000% seconds are found to be at increased risk for post-operative cognitive 
decline.  
For example, 
 an rSO2 of 48 (2 points below 50) could remain there for 3000 seconds before 
reaching the 6000% seconds threshold (2 x 3000 seconds, or 50 minutes, = 6000). 
 
Applying this calculation helps clinicians to track the risk for post-operative cognitive 
decline when  either the rSO2 value or time is increased (Slater, Guarino, Stack, 
Vinod, Bustami, Brown, Rodriguez, Magovern, Zaubler, Freundlich Parr, 2009). 
 
For example, 
 45 rSO2 (5 x 1200 seconds, or 20 minutes, = 6000% seconds) 
 40 rSO2 (10 x 600 seconds, or 10 minutes, = 6000% seconds) 
 35 rSO2 (15 x 400 seconds, or 6.6 minutes, = 6000% seconds) 
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Figure 2.6 Common Times for rSO2 reactions (adapted from Somanetics®, 2005 (b)). 
 
2.4.1.2 Traditional Parameters versus rSO2 
 
Traditionally a variety of parameters are used to establish whether or not oxygen 
supply is meeting oxygen demand (Murkin, 2004): 
 Heart rate (HR) 
 Blood pressure (BP) 
 Pulse oximetry (SpO2) 
 Central venous oximetry (SvO2) 
 Arterial blood gasses (ABG) and  
 Serial Lactate Levels  
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However, the most important ones are SpO2, SvO2 and lactate and these 
parameters will be compared to rSO2 in the section below. 
 
(a) rSO2 versus Pulse Oximetry (SpO2) 
 
A comparison between cerebral oximetry (NIRS) and pulse oximetry is displayed in 
Table 2.3.  The major differences between the two are summarized as: 
 
 rSO2 reflects predominately venous blood and it evaluates the balance 
between oxygen delivery and oxygen consumption, where as pulse oximetry 
only measures arterial blood oxygenation.  
 rSO2 measure oxygenation specific to the brain (end-organ perfusion). SpO2 is 
a global measure of oxygenation in the periphery. 
 rSO2 eliminates the need for pulsatility and flow, as are required for SpO2 
(Somanetics®, 2005 (a)). 
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Table 2.3 Comparison between Pulse Oximetry and Cerebral Oximetry (adapted 
from Tan, 2008) 
 PULSE OXIMETRY CEREBRAL OXIMETRY 
Light transmission Transmission (usually) Reflectance 
Wavelength 660/940 nm 730/810 nm 
Arterial Component Mainly arterial 25% arterial: 75% venous 
Oxygen saturation Hb (arterial) Cerebral venous saturation 
LED 1 Emitter / 1 sensor 1 Emitter / 2 sensors 
Validation In volunteers In volunteers 
Limitation Diathermy Diathermy 
Pulsatility Pulsatile Non-pulsatile 
 
 
(b) rSO2 versus mixed Venous Oxygen Saturation (SvO2) 
 
 rSO2 is non-invasive in nature which avoid added stress on critical ill patients. 
 rSO2 (regional balance between oxygen supply and demand) correlates well 
with invasive measured SvO2 (global indicator of balance between oxygen 
supply and demand). 
 Alerts against regional hypoperfusion which can occur even when SvO2 values 
are within normal range due to alterations in regional vascular resistance. 
 Indwelling catheters are associated with infection, thrombosis, and bleeding 
upon removal, therefore rSO2 eliminates those risk factors (Somanetics®, 2005 
(a)). 
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(c) rSO2 versus Lactates 
 
 Regional organ-specific information versus lactate's global reflection of cellular 
metabolism without oxygen occurring somewhere in the body. 
 rSO2 values will change immediately if tissue oxygen supply is not meeting tissue 
oxygen demand. Lactate is a later indicator of anaerobic metabolism and 
accumulates by-products (lactate), which means ischemic injury has already 
occurred (Somanetics®, 2005 (a)). 
 
  2.5 HEMODYNAMIC MONITORING DURING CABG SURGERY 
 
Ischemic episodes may be associated with frank hemodynamic disturbances like 
the presence of tachycardia and systolic hypotension but usually these episodes are 
associated with little hemodynamic change.  The absence of hemodynamic 
change during ischemic episodes of CABG suggests that regional rather than global 
factors are responsible for the genesis of ischemia (Tupper-Carey, Newman, Price, 
Walesby, Ridout, Feneck, 2000).  NIRS might be a much more sensitive tool to detect 
episodes of ischemia in these CABG patients. 
 
2.5.1 HEART RATE 
 
An electrocardiogram (ECG) gives information regarding ischemia, arrhythmias, 
electrolyte imbalances and drug toxicity (Webster, 1999). 
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Decrease cardiac performance result in an increase in brain oxygen extraction 
which will lower oximetry values (Daubeney, Pilkington, Janke, Charlton, Smith, 
Webber, 1996). 
 
2.5.2 MEAN ARTERIAL PRESSURE (MAP) 
 
When peripheral vascular resistance (PVR) is constant, arterial blood pressure is 
proportional to cardiac output. The arterial pressure is usually affected by any 
changes in volume status of the patient, vasomotor tone and cardiac output. Blood 
flow to the tissues is dependent on the mean arterial pressure (Webster, 1999). 
Edmonds and co-workers (2004) stated that the lower limit of auto-regulation varies 
widely among patients, from MAP < 40 mmHg to > 100 mmHg. 
 
2.5.3 CENTRAL VENOUS PRESSURE (CVP) 
 
Central venous pressure (CVP) has been used to assess the volume status of the 
patient. An increase in CVP may be the result of the manipulation of the heart or 
even of the Superior Vena Cava (SVC) cannula (Urdaneta and Gravenstein, 1999). 
 
Normal values for CVP 
 Pre-CPB - < 10 mmHg 
 During CPB - 0 mmHg (increased with obstruction to venous flow) 
 Coming off CPB - <10 mmHg (Evans, Dunningham and Wallwork, 2009; 
Magder, 2007). 
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CVP values themselves do not provide clinical data that is useful; it must be 
interpreted keeping the patient‟s condition and if possible the cardiac output in 
mind (Madger, 2006). 
 
2.5.4 TEMPERATURE 
 
Temperature has an important effect on tissue oxygenation; even mild hypothermia 
will diminish the severity of ischemia. Hypothermia causes the oxygen dissociation 
curve to shift to the left, resulting in a possible decrease in tissue oxygenation (Nollert, 
Möhnle, Tassani-Prell and Reichart, 1995). Mora, Henson and Weintraub, 1996 have 
shown that cardiac patients undergoing normothermic CPB is at increased risk of 
cerebral desaturation. 
 
In a randomized trial by Regragui and co-workers (1995), three groups of patients 
were evaluated at different temperatures, 28ºC, 32ºC and 37ºC. The minimum post-
operative dysfunctions were recorded in the 28ºC group, but they suggested that 
perfusion temperature has no effect on renal function (Regragui, Izzat, Birdi, Lapsley, 
Bryan, and Angelini, 1995). 
 
Re-warming, on the other hand, can be a cause of neurological dysfunction after 
cardiopulmonary bypass, and full re-warming to 37ºC should be avoided. 
Hyperthermia increases the oxygen demand of the body (Cook, Orszulak, Daly, and 
Buda, 1996). 
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2.5.5 URINE OUTPUT 
 
In the event of cardiopulmonary bypass, low perfusion flow, hypotension, 
vasoconstriction and microembolism may occur resulting in reduced renal blood 
flow. The best way to measure adequate kidney perfusion is to monitor urine output 
and the best way to keep optimal kidney perfusion intra-operatively is to limit CPB 
time and to keep MAP > 60 mmHg (Pramodh, Vani, and Muralidhar, 2003). Urine 
output should be a minimum of 0.5 to 1.0 ml/kg/hr, and any decrease below these 
values should be investigated (Salenger, Gammie and Vander Salm, 2003).  
 
2.5.6 THE EFFECT OF HEART MANIPULATION / STABILIZATION ON 
 HEMODYNAMIC DATA 
 
During OPCAB, hemodynamic changes often occurs during surgical displacement 
of the heart which mainly involves changes in arterial and venous pressures, 
intraventricular volumes, cardiac output and mixed venous oxygen saturation. 
Manipulation resulting in hypotension is associated with an increase in filling pressure 
(Couture, Denault, Limoqes, Sheridan, Babin, and Cartier, 2002). 
 
Stabilization technique can be the cause of hemodynamic changes. Dislocation of 
the heart causes a 26% decrease in MAP and a 37% decrease in cardiac output 
(Couture et al., 2002). 
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  2.6  POST-OPREATIVE OUTCOMES / COMPLICATIONS 
 
2.6.1 CLINICAL OUTCOMES 
 
One of the most controversial debated issues in cardiothoracic surgery is whether 
CABG without the use of CPB and cardioplegia is superior to CABG with CPB and a 
chemically arrested heart (Sellke, DiMaio, Caplan, Ferguson, Gardner, Hiratzka , 
Isselbacher, Lytle, Mack, Murkin and Robbins, 2005).  However, controversy exits 
regarding the selection of patients, who are likely to benefit from the procedure and 
on the claims of improved outcome.  Initially OPCAB revealed excellent results in 
regard to the amount of resources needed, decreased blood loss, decreased 
morbidity and a shortened hospital stay, however the majority of these studies were 
non-randomized clinical reports rather than controlled clinical studies (Sellke et al., 
2005).  Whether OPCAB is associated with a distinct advantage in comparisons to 
CABG with CPB (the golden standard) remains debatable. 
 
Sellke et al. (2005) reviewed various research studies conducted on this topic and 
the pro's and con's of the two procedures are summarized in Table 2.4.  Ultimately 
they concluded that whether a patient benefit from the golden standard on-pump 
CABG or the OPCAB technique depend more on familiarity, comfort, and the skill of 
the surgeon rather than on an intrinsic benefit. Both of these procedures usually 
result in excellent outcomes but neither should be judge to be inferior to the other 
(Sellke et al., 2005). 
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Table 2.4 Findings favouring on-pump CABG and OPCAB (adapted from Sellke et 
 al., 2005) 
Findings favouring OPCAB 
(a)  Probably less bleeding 
(b)  Probably less renal dysfunction 
(c)  Probably less short-term neurocognitive dysfunction, especially if the aorta is calcified 
(d)  Possibly shorter overall length of hospital stay 
Findings favouring on-pump CABG
(a)  Less Technically demanding 
(b)  Shorter "learning curve" 
(c)  Possibly better long-term graft patency 
(d)  Easier to graft posterior (circumflex) bypass targets 
(e)  Probably more bypass grafts constructed 
 
2.6.2 POST-OPERATIVE COMPLICATION ANALYSIS 
 
The Society of Thoracic Surgeons Adult Cardiac Database were used as a measure 
to assess surgical outcomes and is represented in Figure 2.7. 
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Figure 2.7 STS Adult Cardiac Surgery Database Post-Operative Complications 
(Adapted from: STS Society of thoracic Surgeons. 2008. STS Adult 
Cardiac Database: Post-Operative Complications [Online]. Version 
2.41. Available from: http://www.ctsnet.org/file/241DataSpecs.pdf 
[Accessed 13/05/2008]). 
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  2.7 RELAVANCE OF THE STUDY 
 
Intra-operative cerebral oxygen desaturation is associated with early postoperative 
neuropsychological dysfunction in patients undergoing cardiac surgery with CPB. 
Microembolism and hypoperfusion is suggested to be the major cause of 
dysfunction. Another potential complication after CPB is renal dysfunction. Again 
hypoperfusion, systemic inflammatory response, and non-pulsatile flow are among 
the causes of dysfunction.  
 
Due to the fact that cognitive deficits is reported for both on-pump and off-pump 
CABG patients efforts are made to improve neuromonitoring during cardiac surgery.  
Literature provide evidence that intra-operative neuromonitoring helps to prevent 
the occurrence of postoperative cognitive dysfunction, decreases hospital stay and 
minimize the adverse effects on vital organs (de Tournay-Jetté, Dupuis, Bherer, 
Deschamps, Cartier and Denault, 2011).  Oximetry monitoring, via Near-Infrared 
Spectroscopy (NIRS), measure regional oxygen saturation (rSO2), and any changes 
in rSO2 reflects changes in the balance between oxygen delivery and consumption.  
The use of NIRS have shown a significant relationship between low rSO2 values and 
neurologic complication, cognitive dysfunction and a prolonged hospital stay in 
CABG patients (de Tournay-Jetté et al., 2011). 
 
Therefore, in this study the value of intra-operative NIRS monitoring will be assessed 
by evaluating the oximetry values and hemodynamic changes in patients 
presenting with acute coronary syndrome as a predictor of clinical 
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outcome/complication in patients that either received coronary bypass graft 
surgery (CABG) on-pump or off-pump. 
 
2.7.1 Aim 
 
The aim of this study is to predict the incidences of complications and clinical 
outcomes in patients with acute coronary syndrome related to reduced cerebral 
perfusion. 
 
 Evaluation of the correlation between cerebral oximetry values and  
hemodynamic changes during CABG (on-pump and off-pump), and its  
impact on post-operative clinical outcomes and complications. 
 
2.7.1.1 Objectives 
 
i. Cognitive assessment, in both on-pump and off-pump CABG patients, by 
performing Mini-Mental State Examination (MMSE) both pre-operatively and 
post-operatively. 
ii. Pre-operative measurement of cerebral oxygen saturation (rSO2) to identify 
baseline. 
iii. Intra-operative measurement of cerebral rSO2 to assess blood flow. 
iv. Comparison of rSO2 values between on-pump and off-pump CABG surgery. 
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v. The relationship between hemodynamic change (blood pressure, heart rate, 
central venous pressure, temperature, and blood gasses) and NIRS in on-
pump and off-pump CABG patients. 
vi. Observation of post−operative clinical outcomes and complications of CABG 
patients. 
vii. Post−operative hemodynamic monitoring (heart rate, blood pressure, central 
venous pressure, temperature, urine output, and blood gasses). 
viii. Identifying intra-operative cerebral risk groups (in both on-pump and off-
pump groups): 
 Group 1 
 Satisfactory Cerebral Blood Flow -  rSO2 > 50 or < 20% drop from baseline. 
 
 Group 2 
Average/Compromised Cerebral Blood Flow = rSO2 < 50 or > 20% drop from 
baseline. 
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 Chapter 3 
METHODOLOGY 
 
  3.1 STUDY LOCATION 
 
The research study was conducted at Universitas Hospital involving the departments 
of Cardiology, Cardiothoracic Surgery, Anaesthesiology and Chemical Pathology 
(NHLS).  Universitas is a State/Private hospital located in Bloemfontein, capital city of 
the Free State, South Africa. 
 
  3.2 STUDY DESIGN 
 
The study design was an observational cross-sectional analytical study that involved 
60 patients (volunteers) with Acute Coronary Syndrome (ACS).  In light of the study 
design it is important to remember that nothing more than associations can be 
proofed from the research study. The 60 patients were recruited from Universitas 
hospital, Bloemfontein and were assigned to take part in the study only when 
informed consent was granted. 
 
 
  
CHAPTER 3: METHODOLOGY 
 
 
52 
  3.3 STUDY LAYOUT 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Schematic presentation of Study Layout  [Acute Coronary Syndrome (ACS); Near-
Infrared Spectroscopy (NIRS); Less-than (<); Greater-than (>); Greater-than or Equal to (≥); Less-
than or Equal to (≤); Mini-Mental State Examination (MMSE); Partial Pressure of Oxygen in the Blood 
(PO2); Arterial Blood Oxygen Saturation (O2 SAT); Haemoglobin (Hb); Arterial Blood Pressure (BP); 
Heart Rate (HR); Cardiac Output (CO); Urea and Electrolytes (U&E)]. 
ON-PUMP 
(n = 30) 
OFF-PUMP 
(n = 30) 
 
CEREBRAL NIRS 
 
CEREBRAL NIRS 
GROUP 1 
< 20 % reduction 
or NIRS value ≥ 50 
value 
GROUP 2 
>20 % reduction 
or NIRS value ≤ 50 
GROUP 1 
< 20 % reduction 
or NIRS value ≥ 50 
GROUP 2 
>20 % reduction 
or NIRS value ≤ 50 
MMSE 
Pre & Post-Operative 
 
HAEMODYNAMIC MONITORING 
pO2, O2 SAT, Hb, BP, HR, CO 
RENAL FUNCTION 
-  U&E 
- Creatinine 
- Urine Output 
POST-OPERATIVE COMPLICATIONS 
- Clinical 
 
60 PATIENTS DIAGNOSED WITH ACS 
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The study involved 60 patients diagnosed with ACS. The group was divided into two 
subgroups which included 30 on-pump Coronary Artery Bypass Graft (CABG) 
patients and 30 off-pump CABG patients (Figure 3.1). 
 
Pre-operative clinical examination for all volunteers included a Mini-Mental State 
Examination, which was done a day before the operation, to evaluate neurological 
dysfunction. A U&E and creatinine blood test was also done pre-operatively and the 
results were used as a baseline value for post-operative assessment. 
 
On the day of surgery all intra-operative hemodynamic data of the patient were 
recorded via the Datex-Ohmeda S/5™ Collect Program. This data included arterial 
blood pressure, central venous pressure and arterial cannula pressure (systolic, 
diastolic and mean), heart rate and nasopharyngeal and esopharyngeal 
temperature.  The total volume of urine excreted was also documented during the 
surgery, to exactly calculate the amount of urine output (ml/kg/h). 
 
Arterial blood gasses were done routinely at 15 minute intervals. The haemoglobin 
(Hb), pO2, and O2 SAT values were used to assess the oxygen transfer. 
Cerebral oximetry values were captured by the INVOS 5100C® Oximeter to assess 
regional oxygen saturation during cardiac surgery. These values were recorded 
every 30 seconds, and were saved then exported after the case to an Excel 
spreadsheet. 
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Post-operatively, the Mini-Mental State Examination  was repeated when the 
patients arrived at the ward after being discharged from the ICU. This examination 
was compared with the pre-operative examination to identify possible neurological 
dysfunctions that could be attributed to the CABG surgery. 
 
Hemodynamic data (arterial blood pressure, central venous pressure, core 
temperature, and urine output) were charted on the ICU chart, and data points at 6 
hour intervals (for up to 84 hours post-operatively) were statistically analyzed. The U&E 
and creatinine results were recorded up to 72 h post - operatively. 
 
Any complications and all outcomes were documented on the Universitas 
Cardiothoracic Database. Complications were recorded according to the STS 
database format (Appendix D). This information was also used to note outcomes in 
the different groups. 
 
  3.4 STUDY POPULATION 
 
3.4.1 Number of Subjects 
 
The study involved 60 patients diagnosed with ACS referred by the department of 
Cardiology, Universitas Hospital. After a thorough physical examination the ACS 
patients (n = 60 patients) were divided into two groups according to the specific 
intervention method, CABG on-pump (n = 30 patients) and off-pump (n = 30 
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patients). It remained the surgeon’s decision whether he/she wants to operate the 
patient on-pump or off-pump and in no way did the study interfere with this decision. 
 
A patient was considered for the clinical study if informed consent  
(Appendix A) was granted by the patient and if the patient met the inclusion criteria 
set for the study. Every patient participating in the study received an information 
leaflet to inform him/her about the project details (Appendix B). 
 
3.4.2 Subject Identification 
 
The patients participating in the study were identified by using their hospital number 
(UM number), therefore, preventing disclosure of patient’s personal details and 
ensuring confidentiality. 
 
3.4.3 In- and Exclusion Criteria 
 
3.4.3.1 Inclusion Criteria 
 
 Patients with acute coronary syndrome 
 Patients must be available for pre- and post surgery interviews. 
 The patient must be able to give informed consent. 
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3.4.3.2 Exclusion Criteria 
 
 Patients with existing organ failures other than congestive heart 
failure 
 
  3.5 ASSESSMENT FOR NEUROLOGICAL DYSFUNCTION 
 
3.5.1 Mini-Mental State Examination 
 
Pre-operative neurological testing (the day before surgery, before the patient was 
administered his/her premedication), the Mini-Mental State Examination (MMSE) or 
Folstein test was done, and the same test was done post-operatively after extubation 
(when transferred to the ward) to determine whether or not neurological dysfunction 
occurred in the patients undergoing cardiac surgery (Figure 3.4). Note, if the patient 
already had his/her premedication the MMSE test was not done but the patient was 
not excluded from the study. 
 Examinations have been done, pre- (day before operation) and post-
operatively (when transferred to the ward), by the same person and were 
explained to each patient in the same way. 
 Each patient received a score out of thirty. 
 Post-operatively, the same examination was done with each patient when 
transferred to the ward. 
 Again a score was given out of thirty. 
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3.5.1.1 Interpretation of Data 
 
 Normal = ≥ 27 out of 30. 
 Mild impairment = a score between 21 and 26 out of 30. 
 Moderate impairment - a score between 11 and 20. 
 Severe impairment = a score ≤ 10 out of 30 (Folstein et al., 2001; Lopez et al., 
2005). 
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MAXIMUM 
SCORE 
SCORE     
      ORIENTATION 
5 (     )   What is the: (year)   (season)  (date)  (day)  (month) 
5 (     )   Where are we: (state)   (county)  (town)  (facility)  (floor) 
    REGISTRATION 
3 (     ) 
  Name three objects and have person repeat them back. Give one point for each correct 
answer on the first trial.    
1. _______   2. _______   3. _______ 
Then repeat them (up to 6x) until all three are learned.   
[Number of trials ____ ] 
    ATTENTION   AND CALCULATION 
5 (     ) 
  Serial 7's.   Count backwards from 100 by serial 7's.  One point for each correct answer.   
Stop after 5 answers.  [ 93  86  79  72  65 ] 
Alternatively spell "world" backwards.  [ D - L - R - O - W ] 
    RECALL 
3 (     ) 
  Ask for the names of the three objects learned above.  Give one point for each correct 
answer. 
    LANGUAGE 
9 (     ) 
  
Name:  a pen (1 point) and a watch (1 point) 
Repeat the following:  "No ifs, ands, or buts" (1 point) 
Follow a three-stage command:  "Take this paper in your [non-dominant] hand, fold it in 
half and put it on the floor". (3 points)  
[1 point for each part correctly performed] 
Read to self and then do: "Close your eyes" (1 point) 
Write a sentence [subject, verb and makes sense] (1 point) 
Copy design [ 5 sided geometric figure; 2 points must intersect]  
(1 point) 
Score:       /30                     Alert           Overtly Anxious            Concentration Difficulty           Drowsy 
CLOSE YOUR EYES 
 
SENTENCE 
 
Figure 3.2 Mini-Mental State Examination (adapted from Folstein et al., 1975). 
CHAPTER 3: METHODOLOGY 
 
 
59 
  3.6 TREATMENT PROCEDURES FOR ACS 
 
After thorough collaboration between the Cardiologists and Cardiothoracic 
Surgeons a decision was made regarding optimal treatment as standard practice for 
patients with ACS.  The patient could have received one of the following treatments: 
 Medical treatment 
 PCI 
 CABG 
 
The study did not influence the surgeon’s decision whether to operate the patient 
on-pump or off-pump.  Taking all factors into consideration it was the surgeon’s 
decision whether on-pump or off-pump surgery will yield the best possible 
outcome for the patient 
 
3.6.1 Surgical Techniques 
 
3.6.1.1 On-pump CABG Surgery 
 
(A) Preparation of the perfusion system in theatre 
 The Stöckert S5 System (Cardiopulmonary bypass system, Serial no: 48E00380 
and 48E00381) was routinely used and the bypass circuit setup included: 
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 Sorin Biomedica Synthesis oxygenator, Ref: 050239, Sorin Group Italy. 
 Medtronic adult membrane pack, Ref: M273102E, Medtronic Inc. Minneapolis, 
USA. 
 Medtronic Myotherm 4:1, Ref: M999214E, Medtronic Inc. Minneapolis, USA. 
 Medex disposable dome for the Medex transducer, Ref: MX960XYP1, Medex 
medical LTD, Lancashire (cardioplegia pressure transducer). 
 
(B) Prior to CPB the circuit was de-aired using the following prime: 
 1L Balsol Infusion, Ref: FSB001000, Fresenius Kabi for Bodene Limited trading as 
Intramed, Port Elizabeth, RSA. 
 12.5 g Mannitol (Intramed Mannitol 25% m/v, 12.5g, 50ml, Ref: FSM 250050, 
Fresenius Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA). 
 30mg Heparin (Heparin Sodium-Fresenius 1000 i.u./ml, Ref: J/8.2/405, Fresenius 
Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA). 
 1g Ranzol (Ranbaxy Ranzol Injection Cefazolin Sodium (Sterile) 1m/Intra Venous 
(I.V.), Ref: 30/20.1.1/0333, Code: MP/DRUGS/28/15/83, Ranbaxy (SA) (Pty) LTD, 
North Centurion, RSA). 
 500ml Gelofusion (Gelofusion Solution for intra venous (I.V.) infusion, Plasma 
Substitute, Ref: 31/8.4/0360, B. Braun Medical (Pty) LTD, Randburg, RSA). 
 
(C) Transducer prepared for measurement of arterial cannula pressure: 
 Edwards Lifesciences pressure monitoring set, Ref: PX600FP, Edwards 
Lifesciences, Irvine, USA. 
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 CritiCare 0.9% Sodium Chloride Injection BP (200ml), Ref: 32/24/0128, Dismed 
CritiCare (Pty) LTD, Midrand, RSA. 
 30mg of Heparin (Heparin Sodium-Fresenius 1000 i.u/ml, Ref: J/8.2/405, Fresenius 
Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA). 
(D) Cardioplegia 
 Two cardioplegia solutions are used in this centre, depending on surgeon’s 
preference: 
 
 (D1) Buckberg solution: 
 Medsol Cardioplegic Induction Solution, Ref: FSM01850I, Fresenius Kabi 
for Bodene Limited trading as Intramed, Port Elizabeth, RSA. 
 Medsol Cardioplegic Maintenance Solution, Ref: FSM01850M, Fresenius 
Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA. 
 Medsol Cardioplegic Reperfusion Solution, Ref: FSM01850R, Fresenius 
Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA. 
 10ml 50% Dextrose added to each bag of cardioplegic solution 
(Dextose-Fresenium 50% (20ml), Ref: V/24/222, Fresenius Kabi for 
Bodene Limited trading as Intramed, Port Elizabeth, RSA). 
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 (D2) Modified St Thomas solution: 
 1000ml cold Ringer-Lactate (Intramed Ringer-Lactate Solution 1000ml 
Infusion, Ref: FSR001000, Fresenius Kabi for Bodene Limited trading as 
Intramed, Port Elizabeth, RSA). 
 50 ml, 4% Albusol (Human Plasma Albumin, Ref: T/30.3/738, National 
Bioproducts Institute, Pinetown, RSA). 
 30 ml, 8.5% Sodium Bicarbonate (Intramed Sodium Bicarbonate 
Injection 8.5% (50ml) m/v, Ref: FSS850050, Fresenius Kabi for Bodene 
Limited trading as Intramed, Port Elizabeth, RSA). 
 200 mg Lignocaine (Lignocaine HCl-Fresenius, Ref: M/4/254, Fresenius 
Kabi for Bodene Limited trading as Intramed, Port Elizabeth, RSA). 
 4 g Magnesium Sulphate (SABAX Magnesium Sulphate 50% Injection 
(1g/2ml) iv/imi, Pharmacological Classification A.24 (Mineral Substitutes, 
Electrolytes), Ref: V/24/253, ADCOCK Ingram Critical Care (Pty) LTD, 
Johannesburg, RSA). 
 30 mmol/L Potassium (SABAX Potassium Chloride 15% Injection, 
Pharmacological Classification A.24 (Mineral Substitutes, Electrolytes), 
Ref: V/24/218, ADCOCK Ingram Critical Care (Pty) LTD, Johannesburg, 
RSA). 
 
(E) Pre operative management of the patient prior to surgery: 
 Somasensors were placed on forehead of the patient. 
 Three point ECG was connected to the patient’s back. 
 Peripheral lines and arterial blood pressure lines were inserted. 
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 Anaesthesia is commenced. 
 Central venous line was inserted. 
 Median sternotomy is performed by the surgeon and saphenous vein grafts 
were harvested from patient’s legs by the assistant. Internal Mammary Artery 
may also be harvested by the surgeon. 
 Full systemic heparinization of the patient was achieved by intravenous 
administration of 4 mg/kg Heparin (Heparin Sodium-Fresenius 1000 i.u/ml, Ref: 
J/8.2/405, Fresenius Kabi for Bodene Limited trading as Intramed, Port Elizabeth, 
RSA. 
 5 minutes after heparin administration activated clotting time (ACT) sample was 
drawn, and ACT were done. 
 The ascending aorta was cannulated and as soon as an ACT of 480 seconds is 
achieved, bypass was commenced. 
 Access to the right atrium and venous blood is obtained through cannulation 
with a two-stage venous cannula via the right atrial appendage. 
 Systemic hypothermia of between 28 to 30 ⁰C was achieved and the alpha-stat 
principle is applied. 
 An antegrade cardioplegia cannula was placed in the aortic root proximal to 
the arterial cannula. This cannula also served as an aortic vent. 
 The ascending Aorta was cross-clamped between the aortic cannula and the 
antegrade cardioplegia cannula. 
 Infusion of cold blood cardioplegia, at ± 20 ⁰C, antegrade into aortic root via 
cardioplegia cannula and were repeated every 20 min. 
 Topical ice slush was applied onto heart. 
 Distal venous anastomoses were performed on the coronary artery. 
 When last distal anastomosis was preformed, rewarming was commenced. 
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 The aortic root was de-aired through the LV vent cannula. 
 The aorta cross clamp was removed from the distal ascending aorta, when 
normothermia is reached.  
 Oxygenated blood was flowed into the bypassed vessels using a manifold. 
 Proximal anasotomosis performed on the distal ascending aorta utilizing a side-
biting clamp. 
 Cardiopulmonary bypass was weaned and stopped. 
 Protamine was given to reverse Heparin. (Three quarters of heparin dosage = 
3mg/kg Protamine Sulphate, (Protamine Sulphate), Ref: 4543/0234, CP 
Pharmaceuticals LTD, Wrexham). 
 Once haemostasis was achieved, mediastinal and pericardial underwater 
drains were inserted. 
 The sternum was wired and the sternotomy closed. 
 
3.6.1.2 Off-pump CABG Surgery 
 
 Somasensors were placed on the forehead of the patient. 
 Three point ECG was connected to the patient’s back. 
 Peripheral lines and arterial blood pressure lines were inserted. 
 Anaesthesia was commenced. 
 The central venous line was inserted. 
 Patient was draped and autologous cell salvage suction/aspiration line was 
given of. 
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 Surgeon performed median sternotomy and the assistant harvested saphenous 
veins from the patient’s legs. Internal Mammary Artery may also be harvested 
by surgeon. 
 1 mg/kg Heparin were given to the patient to partially heparinize the patient, 
(Heparin Sodium-Fresenius 1000 i.u/ml Ref: J/8.2/405, Fresenius Kabi for Bodene 
Limited trading as Intramed, Port Elizabeth, RSA). 
 The distal venous anastomoses onto the coronary artery were performed using 
one of 3 stabilizers to stabilize the area. 
- Medtronic Octopus 4, Ref: 29400,Medtronic Inc. Minneapolis, USA 
- Medtronic Starfish 2, Ref: 29800, Medtronic Inc. Minneapolis, USA 
- Genzyme stabilizer, Ref: TX180010, Thebe Medical, Johannesburg, RSA 
 A coronary shunt may be used by the surgeon. 
- Medtronic Clear view 1.5mm, Ref: 31150, Medtronic Inc. Minneapolis, USA 
 A water-filled glove was placed posterior to the heart and steadily inflated in 
order to bring the heart more anterior if necessary or a posterior pericardial 
stitch and vaginal swab can be used to facilitate better exposure of the 
coronary arteries. 
 Proximal anastomoses were performed on the ascending aorta utilizing a side-
biting clamp. 
 Protamine was given to reverse Heparin. (Three quarters of heparin dosage = 
mg/kg Protamine Sulphate dosage). 
- Prosulf (Protamine Sulphate), Ref: 4543/0234, CP Pharmaceuticals LTD, 
 Wrexham 
 Once haemostasis was obtained, mediastinal and pericardial underwater 
drains are inserted. 
 Sternum were wired and the sternotomy was closed. 
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  3.7 CEREBRAL rSO2 MEASUREMENTS 
 
Non-invasive measurement was performed using two sensors, called Somasensors. 
Harmless near-infrared light passed through the patient’s forehead and into the 
brain. With the two detectors at different distances from the light source, two depths 
of penetration were measured. The difference in these measurements eliminates 
signals common to both, minimizing changes occurring in the extra-cranial tissues. 
3.7.1 Procedure 
 
 The patient’s head (for cerebral blood flow) was cleaned with Hibitane to 
avoid any interference with the sensors and for accurate readings. The 
skin was dried before the sensors were applied. 
 The sensors were applied in the middle of the forehead (Figure 3.2), the 
cables were connected to the sensors and to INVOS 5100C® Oximeter 
(Figure 3.3) (Manufacturer: Somanetics, Serial no: 07-10224, Model: 5100C, 
License no: 432/12008). 
 After connecting the cables the baseline was set on the INVOS Cerebral 
Oximeter by pressing the “SET BASELINE” button. 
 Following the baseline setting, every 30 seconds readings were monitored 
and recorded on the INVOS Cerebral Oximeter throughout the 
procedures. 
 Post-operatively, the data were downloaded via a memory stick and 
were then exported to an Excel spreadsheet on a computer. 
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3.7.2 Interpretation of Cerebral Data 
 
 With every event values were recorded. 
 Patients were divided into 2 groups: 
 Group 1: Satisfactory cerebral blood flow (NIRS values > 50 or  
< 20% drop from baseline). 
 Group 2: Compromised cerebral blood flow (NIRS values ≤ 50 or  
≥ 20% drop from baseline). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3  SomaSensors placed on patient’s forehead (Adapted from Piacentini, 
2000). 
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Figure 3.4 INVOS 5100C® Machine and SomaSensors (Adapted from: Somanetics®, 
2005(c). Available from: http://www.somanetics.com/invos-system. 
[Accessed 13/05/2008].) 
 
  3.8 HEMODYNAMIC MONITORING 
 
3.8.1 Datex-Ohmeda S/5TM 
 
The hemodynamic data was captured electronically via the Datex-Ohmeda S/5 ™ 
monitors in theatre (Datex-Ohmeda S/5 ™ Cardiovascular Anaesthetic monitor Serial 
no: 90027365 and 4416799) onto a computer throughout surgery. The data was 
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captured every 10 seconds on the Datex-Ohmeda S/5™ Collect Program, which was 
then converted by the Datex-Ohmeda software into an Excel spreadsheet (Datex-
Ohmeda S/5™ Collect, GE Healthcare software, Ref: L-COLLECT4-01-EN, SN: 6521804, 
GE Healthcare, Finland). This information is then processed, and every 5 minutes 
values were used to determine the average values in each group. 
 
 Heart rate - recorded via 3 lead ECG. 
 Arterial Blood Pressure – placement in Radial artery. 
 Central Venous Pressure (CVP) – placement in Internal Jugular Vein. 
 Temperature – temperature probe was placed Nasopharyngeal and 
Esopharyngeal. 
 Urine output – urine catheter through the urethra up to the bladder. 
 Event marking was done intra-operatively. This was done electronically on the 
INVOS and manually on paper. The INVOS machine has a function that by 
pressing the “EVENT” button on the screen, a list of all possible events appears, 
and the suitable events can be marked by pressing the “SELECT” button on 
the screen. 
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Table 3.1 Listed events for on-pump CABG Surgery (Adapted from: Somanetics®, 
2005(c). Available from: http://www.somanetics.com/invos-system. [Accessed 
13/05/2008]). 
ON-PUMP CABG EVENTS 
 Baseline  Intubation  Incision 
 Tachycardia  Bradycardia  Blood drained 
 Cannulate  On CPB  Increase MAP 
 Decreased CO2  Pump flow decrease  Pump flow increase 
 Stop flow  Hemoconcentrate  Cardioplegia 
 Cross clamp on  Cross clamp off  Side clamp on 
 Side clamp off  Blood transfusion  CPB terminated 
 Reposition heart  Manipulate heart  Reposition clamp 
 Paced  Defibrillated  Bleeding 
 IABP on  Chest closed  Atrial Fibrillation 
 Reposition head   Heparin administered 
 
Table 3.2 Listed events for off-pump CABG Surgery (Adapted from: Somanetics®, 
2005(c). Available from: http://www.somanetics.com/invos-system. [Accessed 
13/05/2008]). 
OFF PUMP CABG EVENTS 
 Baseline  Intubation  Incision 
 Tachycardia  Bradycardia  Blood drained 
 Decreased CO2  Blood transfusion  Increase MAP 
 Side clamp off  Manipulate heart  Side clamp on 
 Reposition heart  Stabilizer off  Reposition clamp 
 Stabilizer on  Defibrillated  Bleeding 
 Paced  Chest closed  Atrial Fibrillation 
 IABP on  Heparin administered  
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  3.9 LABORATORY ANALYSIS 
 
3.9.1 U&E and Creatinine 
 
The U&E and Creatinine were done routinely as requested by the medical 
practitioner overseeing the patient. All these tests were performed in accordance 
with the standard operating procedures as accredited by the National Health 
Laboratory Service (NHLS). 
 
  3.10 POST-OPERATIVE COMPLICATIONS 
 
The Society of Thoracic Surgeons Adult Cardiac Database (Figure 3.4) was used 
as a measure to assess surgical outcome (Adapted from: STS Society of 
thoracic Surgeons. 2008. STS Adult Cardiac Database: Post-Operative 
Complications [Online]. Version 2.41. Available from: 
http://www.ctsnet.org/file/241DataSpecs.pdf [Accessed 13/05/2008]). 
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Figure 3.5 Post-operative complications recorded by STS Adult Cardiac Database 
(Adapted from: STS Society of thoracic Surgeons. 2008. STS Adult 
Cardiac Database: Post-Operative Complications [Online]. Version 
2.41. Available from: http://www.ctsnet.org/file/241DataSpecs.pdf 
[Accessed 13/05/2008]). 
Mortality  
in hospital death or long-
term 
Length of hospital stay  
duration from operation 
to discharge 
ICU length of stay  
 intensive care stay 
Return to ICU  
readmitted to the ICU 
after an initial stay 
Ventilation time  
 hours on the ventilator 
Re-intubation  
 re-intubated during 
hospital stay 
Re-operation  
 re-operation due to 
bleeding/tamponade or 
any other cardiac 
complication 
Peri-operative 
myocardial infarction 
Pulmonary complications  
prolonged ventilation, 
pulmonary embolism, 
pneumonia 
Neurological 
complications  
transient stroke, 
permanent stroke, 
postoperative coma 
Renal complications  
renal failure 
Multi system failure 
Gastrointestinal 
complications 
Postoperative dissection 
of the aorta, femoral or 
ileal artery 
Acute limb ischemia 
Heart block  
requiring a permanent 
pacemaker prior to 
discharge 
Atrial fibrillation Cardiac arrest 
Anticoagulant 
complications 
Tamponade 
Sternal wound infection Thoracotomy infection Leg infection Septicemia 
Urinary track infection Postoperative CK-MB 
Postoperative blood 
products used 
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  3.11 STATISTICAL ANALYSIS 
 
Data was captured using a Microsoft Excel spreadsheet. The statistical analysis was 
done by a qualified statistician using SAS Version 9.1.3. The data was summarized 
using descriptive statistics, namely frequencies and percentages for categorical 
data. Means and standard deviations or medians and percentiles were used to 
summarize numerical data. Analytical statistics compared the frequencies and 
percentages in different groups by using the Chi-square statistic to calculate  
p-values. Means or medians of different groups were compared using the T-test or 
Kruskal-Wallis test to calculate p-values. Significant differences were noted at  
p < 0.05. 
 
Firstly, the on-pump and off-pump groups were compared to assess whether the two 
groups of patients were comparable regarding demographic, risk profiles and intra-
operative data. Thereafter the following analyses were conducted:  
 
3.11.1 Analysis 1:   Cerebral NIRS performed on on-pump and off-pump 
CABG groups 
 
In order to assess the impact of surgical techniques on cerebral blood flow, using 
NIRS as a monitoring instrument. Outcomes were compared between patients 
undergoing on-pump versus off-pump CABG procedures. 
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3.11.2 Analysis 2:  Comparison of cerebral NIRS values between 
Group 1( rSO2= ≥ 50, < 20% drop from baseline value)  
and Group 2  (rSO2  < 50, > 20% drop from baseline 
value) irrespective of Surgical Technique 
 
Published data on neurological outcomes were used to divide all patients into two 
groups, irrespective of bypass technique, in order to determine the predictive value 
of impaired cerebral flow on patient outcomes. 
 
Group 1 had NIRS values of more than 50 or a less than 20 % drop from the baseline 
value.  Group 2 had NIRS values of less than 50 or a drop of more than 20% from the 
baseline value. The lowest value recorded during the procedure was captured and 
used irrespective of the amount of time that value was sustained.  Patient outcomes 
were then analyzed in accordance. 
 
The Mini-mental State Examination, renal function (U&E and creatinine, urine output, 
and urine electrolytes), and clinical outcomes were analyzed to evaluate the 
relationship between NIRS values or trends and outcomes, irrespective of surgical 
technique used. 
 
In order to assess the intra- group predictive value of cerebral NIRS measurements, 
each surgical group was then analyzed separately. 
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3.11.3 Analysis 3:  Comparison of Cerebral NIRS values between 
Group 1 (rSO2 > 50; < 20% drop from baseline value) & 
Group 2 (rSO2 ≤ 50; > 20% drop  from baseline value) in 
patients receiving On-Pump CABG surgery 
 
On-pump CABG patients were divided into two groups, Group 1 had NIRS values 
more than 50 or less than 20% drop from the baseline value and Group 2 had NIRS 
values of less than 50 or a drop of more than 20% from the baseline value. 
 
Patient outcomes were analyzed. Mini-mental State Examination, renal function (U&E 
and creatinine, urine output, and urine electrolytes), and clinical outcomes were 
analyzed to evaluate the relationship of NIRS values or trends and outcomes in 
patients that received on-pump CABG surgery. 
 
3.11.4 Analysis 4:  Comparison of Cerebral NIRS values between 
Group 1 (rSO2 > 50; < 20% drop from baseline value)  & 
Group 2 (rSO2 ≤ 50; > 20% drop from baseline value) in 
patients receiving Off-Pump CABG surgery 
 
During this analysis, all off-pump CABG patients were divided into two groups (Group 
1 had NIRS values more than 50 or a less than 20% drop from the  baseline value and 
Group 2 had NIRS values of less than 50 or a drop of more than 20% from the baseline 
value). 
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Patient outcomes were analyzed. Mini-mental State Examination, renal function (U&E 
and creatinine, urine output, and urine electrolytes), and clinical outcomes were 
analyzed to evaluate the relationship between NIRS values/trends and outcomes in 
patients that received off-pump CABG surgery. 
 
  3.12 ETHICAL ASPECTS AND GOOD CLINICAL PRACTISE 
 
3.12.1 Ethical Clearance 
 
The study was ethically approved by the Ethics Committee, University of the Free 
State, Bloemfontein (ETOVS No. 51/07B). The study strictly adheres to all the ethical 
guidelines outlined by the Ethics Committee of the University of the Free State 
(Appendix E). 
 
3.12.2 Safety Variables 
 
3.12.2.1 Patient Safety 
 
Patients participating in this study were well monitored and could at any time 
discontinue their participation without influencing their quality of care. 
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3.12.2.2 Good Clinical Practice (GCP) / Quality Assurance 
 
All clinical work conducted under this protocol is subjected to the GCP guidelines 
(The Principles of the Declaration of Helsinki, GCP, 2004). 
 
The declaration of Helsinki’s basic principle number 3 states that research should be 
conducted only by scientifically qualified people and under the supervision of 
adequately qualified people (World Medical Association, 2002). 
 
3.12.2.3 Financial Implications to the Patient 
 
No financial constraint was inflicted on the patient if he/she participated in the study 
and no financial remuneration was given if a patient decided to participate in the 
study. 
 
3.12.2.4 Withdrawal Criteria 
 
Participation was completely voluntarily.  Patients had the right to withdraw from this 
particular study at any time, irrespective the reason(s), without detriment to their 
medical care at present or in future.  The elimination of a patient from this particular 
study, did not involve any penalties. 
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3.12.2.5 Subject Information and Informed Consent 
 
All the patients were informed about the purpose and necessity of the research 
project, the financial implications and the consequences as well as the adverse 
effects and their right to withdrawal without any effects on them or their doctor-
patient relationship.  They signed an informed consent form (Appendix A) and 
received an information sheet (Appendix B). 
 
3.12.2.6 Confidentiality 
 
The personal details of every patient that participated in this the study were kept 
confidential, as far as possible. At no time during the research have any of the 
patients’ identification details been made known to any other people other as to 
whom the patient gave his/her consent to. 
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  4.1 INTRODUCTION 
 
Sixty patients that presented with Acute Coronary Syndrome (ACS) who received 
Coronary Artery Bypass Graft Surgery (CABG) were observed during this study. Thirty 
patients underwent on-pump CABG and 30 patients received off-pump CABG 
surgery.  
 
4.1.1 Statistical Analysis 
 
Data was captured using a Microsoft Excel spreadsheet. The statistical analysis was 
done by a qualified statistician using SAS Version 9.1.3. The data was summarised 
using descriptive statistics, namely frequencies and percentages for categorical 
data. Means and standard deviations or medians and percentiles were used to 
summarize numerical data. Analytical statistics compared the frequencies and 
percentages in different groups by using the Chi-square statistic to calculate p-
values. Means or medians of different groups were compared using the t-test or 
Kruskal-Wallis test to calculate p-values. Significant differences were noted at  
p < 0.05. 
 
Four different analyses were performed to compare the two groups (on-pump versus 
off-pump) and the risk groups identified (adequate cerebral perfusion versus 
 Chapter 4 
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inadequate cerebral perfusion).  A short description of each of the four analyses is 
illustrated in Figure 4.1. 
 
Figure 4.1 Schematic description of Data Analysis 1-4 
Analysis 1 
•Cerebral  NIRS performed on on-pump (n=30) and off-pump (n=30) CABG groups 
Analysis 2 
•All 60 patients (regardless whether the patient received on-pump or off-pump CABG) 
were divided into 2 groups according to cerebral NIRS values (Group 1:  satisfactory 
cerebral blood flow ≥ 50, < 20% drop from baseline value; Group 2: 
averaged/compromised satisfactory cerebral blood flow ≤ 50, > 20% drop from baseline 
value). These groups were then compared with post-operative outcomes and 
complications which includes the Mini-Mental State Examination, renal function (U&E, 
creatinine and urine output) and any other complication according to the STS Adult 
Cardiac Database. 
Analysis 3 
•The 30 patients, who received on-pump CABG, were divided into 2 groups according to 
cerebral NIRS values (Group 1: sataisfactory satisfactory cerebral blood flow ≥ 50, < 20% 
drop from baseline value; Group 2: average/compromised satisfactory cerebral blood 
flow ≤ 50, > 20% drop from baseline value). These groups were then compared with intra-
operative data (O2, O2 saturation, hemoglobin, systolic and mean arterial blood pressure, 
heart rate, and cardiac output), and post-operative outcomes and complications which 
includes the Mini-Mental State Examination, renal function (U&E, creatinine and urine 
output) and any other complication according to the STS Adult Cardiac Database. 
Analysis 4 
•The 30 patients, who received off-pump CABG, were divided into 2 groups according to 
cerebral NIRS values (Group 1: satisfactory cerebral blood flow ≥  50, < 20% drop from 
baseline value; Group 2: averaged/compromised cerebral blood flow ≤ 50, > 20% drop 
from baseline value). These groups were compared with intra-operative data (O2, O2 
saturation, hemoglobin, systolic and mean arterial blood pressure, and heart rate), and 
post-operative outcomes and complications which includes the Mini-Mental State 
Examination, renal function (U&E, creatinine and urine output) and any other 
complication according to the STS Adult Cardiac Database. 
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 4.2  DEMOGRAPHIC AND CLINICAL DATA, ON-PUMP AND OFF-
PUMP CABG PATIENTS 
 
4.2.1 Pre-operative demographic and clinical data (on-pump and 
off-pump) 
 
The demographic data and pre-operative clinical characteristics for both on-pump 
and off-pump CABG patients are displayed in Table 4.1. Although the groups were 
limited in numbers they revealed similar and comparable data.  The data for both 
the on-pump and off-pump CABG groups revealed no statistical significant 
differences (Table 4.1) for the EuroSCORE, age, gender, weight, height, Body Mass 
Index (BMI) and Body Surface Area (BSA). In both groups more males presented with 
Acute Coronary Syndrome [on-pump, n=27 (90%) versus (off pump, n=23 (76.67%)]. 
 
Pre-operatively, Acute Coronary Syndrome was classified as unstable angina, STEMI, 
and NONSTEMI. No differences were found between the two groups.  In the on-
pump CABG group, 83% (n=25) of the patients presented with unstable angina, 26% 
(n=8) with STEMI and 73% (n=22) with NONSTEMI. In the patients receiving off-pump 
CABG surgery, 73% (n=22) patients presented with unstable angina, 10% (n=3) with 
STEMI and 90% (n=27) with NONSTEMI (Table 4.1). 
 
The only statistical significant difference between the on-pump and off-pump CABG 
groups were the last myocardial infarctions noted at admission to Cardiology 
(p=0.0326). A total of 14 patients in the on-pump group had a myocardial infarction 
less than 6 hours prior to admission compared to 5 in the off-pump group (Table 4.1). 
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Pre-operative risk factors such as diabetes, smoking, renal insufficiency, neurological 
complication, hypertension, and peripheral vascular disease did not reveal any 
statistical significant differences between the two groups. Only one patient in the 
off-pump CABG group had a previous stroke (3.33%), but fully recovered. In both 
groups, 20% (n=6) of patients had mild pre-operative Coronary Obstructive 
Pulmonary Disease (COPD).  In the on-pump CABG group 3.33% (n=1) of patients 
presented with moderate COPD and in the off-pump CABG group 3.33% (n=1) had 
severe COPD and 10% (n=3) had mild COPD with asthma (Table 4.1). 
 
The pre-operative MMSE showed no difference in the two groups and no cognitive 
impairment could be demonstrated.  However, this data could be compromised 
due to patients refusing to take the test, educational level, and pre-operative 
medication.   
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Table 4.1 Demographic and Pre-operative Clinical Data for on-pump and off-
pump CABG patients 
DEMOGRAPHIC DATA ON-PUMP 
(n=30) 
OFF-PUMP 
(n=30) 
p-value 
EuroSCORE %    
Median 4.03 3.33 0.3867 
25th percentile 2.64 1.83 - 
75th percentile 7.12 6.32 - 
Age (years)    
Mean 59.13 61.20 0.3679 
Std Dev 8.58 9.05 - 
Height (cm)    
Mean 177.03 176.50 0.8383 
Std Dev 10.54 9.58 - 
Weight (kg)    
Mean 87.13 91.47 0.4129 
Std Dev 19.45 21.21 - 
BSA (m²)    
Mean 1.99 2.01 0.8199 
Std Dev 0.25 0.36 - 
BMI (kg/m²)    
Mean 27.99 29.42 0.3412 
Std Dev 5.89 5.46 - 
Gender    
Male n = 27 (90%) n = 23 (76.67%) 
0.1659 
Female n = 3 (10%) n = 7 (23.3%) 
PRE-OPERATIVE CLINICAL DATA    
LVEF %    
Mean 51.32 55.68 0.2258 
Std Dev 15.19 12.17 - 
MMSE n = 24 n = 23  
Median 28.50 28.00 0.6109 
25th percentile 24.50 25.00 - 
75th percentile 29.00 29.00 - 
Haemoglobin (kPa)    
Median 14.20 13.60 0.1254 
25th percentile 13.30 12.20 - 
75th percentile 15.10 15.00 - 
Minimum 8.60 9.80 - 
Smoking    
Ex-smoker 6 (20.00%) 12 (40.00%) 
0.2345 Never 6 (20.00%) 4 (13.33%) 
Current 18 (60.00%) 14 (46.67%) 
Renal Insufficiency    
None - - - 
Neurological dysfunction    
None - - - 
Neurological disease    
CVA with full recovery - 1 (3.33%) - 
Pulmonary Disease    
Mild COPD 6 (20.00%) 6 (20.00%) 
0.2992 
Moderate COPD 1 (3.33%) - 
Severe COPD - 1 (3.33%) 
Asthma + mild COPD - 3 (10.00%) 
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Peripheral Vascular Disease    
None - - - 
Carotid Bruits    
None - - - 
Creatinine (mEq/L)    
Median 94.50 96.00 0.7844 
25th percentile 86.00 80.00 - 
75th percentile 105.00 107.00 - 
Urea (mEq/L)    
Median 4.70 4.50 0.5441 
25th percentile 3.70 3.60 - 
75th percentile 5.70 5.20 - 
Sodium (mEq/L)    
Median 140.00 139.00 0.3244 
25th percentile 138.00 137.00 - 
75th percentile 141.00 140.00 - 
Potassium (mEq/L)    
Median 4.15 4.05 0.8936 
25th percentile 3.90 3.70 - 
75th percentile 4.40 4.40 - 
Chloride (mEq/L)    
Median 107.00 107.00 0.5123 
25th percentile 105.00 105.00 - 
75th percentile 109.00 109.00 - 
Acute Coronary Syndrome    
Unstable Angina n = 25 (83.33%) n = 22 (73.33%) 0.0835 
STEMI n = 8 (26.67%) n = 3 (10.00%) 0.0953 
NONSTEMI n = 22 (73.33%) n = 27 (90.00%) 0.0953 
Previous MI    
One n = 8 (26.67%) n = 3 (10.00%) 
0.1024 
Two or more n = 14 (46.67%) n = 12 (40.00%) 
Last previous MI upon admission to Cardiology  
Unknown n = 10 (33.337%) n = 18 (60%)  
< 6hrs n = 14 (46.67%) n = 5 (16.67%) 
0.0326 
6 – 24hrs n = 1 (3.33%) n = 1 (3.33%) 
1 – 30 days n = 5 (16.67%) n = 4 (13.33%) 
31 – 90 days - - 
> 90 days - n = 2 (6.67%) 
Previous non-surgical intervention    
Previous PCI n = 3 (10.00%) n = 2 (6.67%) 0.6707 
Dyspnoea    
NYHA I n = 8 (26.67%) n = 3 (10.00%) 
0.2564 
NYHA II n = 18 (60.00%) n = 23 (76.67%) 
NYHA III n = 4 (13.33%) n = 3 (10.00%) 
NYHA IV - n = 1 (3.33%) 
Diabetes    
Diet n = 1 (3.33%) n = 5 (16.67%) 
0.3489 Oral therapy n = 3 (10.00%) n = 4 (13.33%) 
Insulin n = 2 (6.67%) n = 2 (6.67%) 
Hypertension    
Treated n = 19 (63.33%) n = 20 (66.67%) 0.1674 
The data is given as mean with standard deviation (Std Dev) or median with 25th and 75th percentile. The p-values 
were calculated with t-test and the Kruskal-Wallis-Test. Categorical variables are demonstrated with an n-value and 
percentages. The p-values were calculated with Chi-square test. A p < 0.05 indicates statistical significance.  
[BSA: Body Surface Area; BMI: Body Mass Index; LVEF: Left Ventricular Ejection Fraction; MMSE: Mini-Mental State 
Examination; STEMI: ST segment Elevation Myocardial Infarction; NONSTEMI: Non ST segment Myocardial Infarction; 
MI: Myocardial Infarction; NYHA: New York Heart Association classification; CVA: Cerebrovascular Accident; COPD: 
Chronic Obstructive Pulmonary Disease]. 
CHAPTER 4: RESULTS 
 
85 
Essentially the patients in the on- and off-pump groups were considered to be similar 
regarding risk factors and co-morbidities. 
  4.3 ANALYSES 1-4 
 
4.3.1 Cerebral NIRS performed on on-pump and off-pump CABG 
patients (Analysis 1) 
 
In order to assess the impact of surgical techniques on cerebral blood flow, using 
NIRS as a monitoring instrument, outcomes were compared between patients 
undergoing on-pump versus off-pump CABG procedures.  The intra-operative data 
between the on-pump and off-pump CABG groups were relatively comparable with 
limited statistical significant differences between the two groups (Table 4.2). The 
number of grafts in the on-pump CABG group ranged from 1 to 5, and in the off-
pump CABG group from 1 to 3, but no statistical significant difference (p = 0.0814) 
was shown between the two groups. 
 
The most important and statistical significant difference (p < 0.0001) was 
demonstrated for cerebral NIRS values.  Twenty six (86.67%) of the on-pump CABG 
patients fell in group 2 (average or compromised cerebral blood flow = <50; ≥ 20% 
drop from baseline) and only five (16.67%) of the off-pump CABG patients fell in 
group 2 (Table 4.2). 
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Table 4.2 Intra-operative data for on-pump and off-pump CABG groups 
INTRA-OPERATIVE DATA 
ON-PUMP 
(n=30) 
OFF-PUMP 
(n=30) 
p-value 
Number of grafts    
1 graft 1 (3.33%) 6 (20.00%) 
0.0814 
2 grafts 12 (40.00%) 14 (46.67%) 
3 grafts 14 (46.67%) 10 (33.33%) 
4 grafts 2 (6.67%) - 
5 grafts 1 (3.33%) - 
Median 3.00 2.00 
25th percentile 2.00 2.00 
75th percentile 3.00 3.00 
Haemoglobin (kPa)    
Median 14.45 13.20 0.0162 
25th percentile 13.80 12.30 - 
75th percentile 15.40 14.90 - 
PO2 (kPa)    
Median 71.15 71.65 0.4246 
25th percentile 66.80 66.10 - 
75th percentile 84.90 126.10 - 
O2SAT (%)    
Median 95.40 95.05 0.8024 
25th percentile 94.20 93.30 - 
75th percentile 96.10 96.60 - 
Cerebral NIRS risk groups    
Group 1 4 (13.33%) 25 (83.33%) 
<0.0001 
Group 2 26 (86.67%) 5 (16.67%) 
Cerebral NIRS    
Median 69.00 65.50 0.3398 
25th percentile 59.00 59.00 - 
75th percentile 74.00 70.00 - 
Heart Rate (beats/min)    
Median 67.00 68.00 0.8605 
25th percentile 62.00 61.00 - 
75th percentile 85.00 75.00 - 
Mean Arterial Pressure (mmHg)    
Median 78.68 116.74 0.4341 
25th percentile 71.27 64.25 - 
75th percentile 92.74 133.87 - 
Systolic Pressure (mmHg)    
Median 115.65 171.45 0.1928 
25th percentile 98.50 97.57 - 
75th percentile 130.29 179.71 - 
Urine output (ml/kg/hr)    
Median 3.38 1.90 0.0030 
25th percentile 2.07 1.29 - 
75th percentile 5.09 2.89 - 
The continuous variables are given as mean with standard deviation (Std Dev) or median with 25th and 75th 
percentile. The p-values were calculated with t-test and the Kruskal-Wallis-Test. Categorical variables are 
demonstrated with an n-value and percentages. The p-values were calculated with Chi-square test.  A p < 0.05 
indicates statistical significance. [CPB: Cardiopulmonary Bypass; PO2: Partial Pressure of Oxygen; O2SAT: Oxygen 
Saturation; NIRS: Near Infrared Spectroscopy; min: minute; ºC: Degrees Celsius; kPa: kilopascal; %: percentage; 
mmHg: millimetres mercury; ml/kg/hr: millilitre per kilogram per hour].  
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Statistical significant differences were also found in intra-operative haemoglobin 
values (p = 0.0162) and urine output (p = 0.0030) although these values were still 
within the normal range.  Three patients in the off-pump group were converted to 
on-pump CABG surgery due to hemodynamic instability or aortic dissection. 
 
4.3.1.1 On-pump and Off-pump Cerebral NIRS linked to Pre-
determined Intra-operative Events 
 
During this analysis the cerebral NIRS values of the on-pump and off-pump CABG 
groups were linked to pre-determined intra operative events in order to reflect the 
hemodynamic impact of events during these procedures on oxygen delivery (as 
reflected by NIRS values).  The results are displayed in Table 4.3. for the on-pump and 
Table 4.4 for the off-pump CABG groups. 
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Table 4.3 On-pump CABG Cerebral NIRS linked to Intra-operative Events 
CEREBRAL NIRS n 
ON-PUMP CABG GROUP 
25th percentile 75th percentile Median 
EVENTS   
Baseline 30 58.25 70.75 66.50 
Intubation 30 71.00 81.25 77.00 
Incision 30 66.00 75.75 69.50 
Tachycardia 2 75.50 78.50 77.00 
Bradycardia 1 56.00 56.00 56.00 
Cannulate 19 65.00 74.00 72.00 
On CPB 30 62.25 73.75 69.50 
Cooling 18 53.75 72.00 58.50 
 MAP 3 63.00 69.00 66.00 
 MAP 5 56.00 73.00 65.00 
Cardioplegia 30 52.25 62.75 58.50 
Clamp on 30 54.00 66.50 60.50 
Clamp off 30 49.25 54.75 51.50 
Side clamp on 30 47.00 57.00 51.00 
Side clamp off 30 51.50 58.25 51.50 
Warming 28 47.75 57.75 54.00 
Off CPB 30 52.00 61.00 58.00 
Chest closed 26 55.25 64.00 59.50 
The continuous variables are given as median with 25th and 75th percentile.  [NIRS: Near Infrared Spectroscopy; MAP: 
Mean Arterial Pressure; CPB: Cardiopulmonary bypass]. 
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Table 4.4 Off-pump CABG Cerebral NIRS linked to Intra-operative Events 
EVENTS n 
OFF-PUMP CABG GROUP 
25th  percentile 75th  percentile Median 
Cerebral NIRS    
Baseline 30 58.00 68.00 64.50 
Intubation 30 72.00 78.00 75.00 
Incision 29 63.00 74.00 70.00 
Tachycardia 4 62.50 77.50 69.50 
Reposition heart 28 61.75 74.25 67.00 
Manipulate heart 3 48.00 63.50 54.00 
Side clamp on 26 60.00 72.00 66.50 
Side clamp off 26 62.00 73.00 68.00 
 MAP 13 58.00 75.00 68.00 
 MAP 16 60.50 75.25 66.50 
Stabiliser on 24 60.00 74.00 63.50 
Stabiliser off 21 56.00 71.00 63.00 
Chest closed 27 59.50 68.00 63.00 
Cannulate 2 68.25 70.75 69.50 
On CPB 3 62.00 69.00 65.00 
Cooling 2 61.50 66.50 64.00 
Cardioplegia 3 42.00 61.00 57.00 
Warming 3 47.00 57.50 54.00 
Clamp on 3 39.50 58.50 52.00 
Clamp off 3 43.50 58.00 56.00 
Off CPB 3 61.50 65.50 63.00 
The continuous variables are given as median with 25th and 75th percentile. [NIRS: Near Infrared Spectroscopy; MAP: 
Mean Arterial Pressure; CPB: Cardiopulmonary bypass]. 
 
As events are non-comparable between the two surgical groups, time lines were 
used and median values were compared between on-pump and off-pump groups 
(Table 4.5). 
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Table 4.5 Comparison between on-pump and off-pump CABG in regards to 
Cerebral NIRS using time lines 
VARIABLES n 
ON-PUMP OFF-PUMP p-
value Mean Std Dev Mean Std Dev 
Cerebral NIRS     
Baseline 30 67.76 10.83 65.20 9.20 0.3268 
T5 30 68.53 10.95 66.53 8.71 0.4371 
T10 30 69.26 11.19 67.96 8.49 0.6144 
T15 30 71.53 9.98 69.70 9.49 0.4690 
T20 30 72.63 8.85 71.23 10.38 0.5764 
T25 30 74.03 7.71 72.66 10.66 0.5690 
The continuous variables are given as mean with standard deviation (Std Dev). The p-values were calculated with t-
test and the Kruskal-Wallis-Test. A p < 0.05 indicates statistical significance. T = 5 minute intervals [NIRS: Near Infrared 
Spectroscopy; Std Dev: Standard Deviation; T: Time]. 
 
Comparing cerebral NIRS vales according to time lines in on-pump (n = 30) and off-
pump (n = 30) CABG patients revealed no statistical significant differences.  
 
4.3.2 Comparison of cerebral NIRS values between Group 1( rSO2= ≥ 
 50, < 20% drop from baseline value)  and Group 2 (rSO2 < 50, > 20% 
 drop from baseline value)  irrespective of Surgical Technique 
 (Analysis 2)  
 
In Analysis 2 all 60 CABG patients, irrespective whether they had on-pump or off-
pump CABG surgery were divided into cerebral NIRS groups 1 and 2.  Group 1 
consisted of patients considered to have satisfactory cerebral blood flow (rSO2 ≥ 50 
;< 20% drop from baseline value) and group 2 had average/or compromised 
cerebral blood flow (rSO2 < 50, > 20% drop from baseline value). 
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4.3.2.1 Near Infrared Spectroscopy (NIRS): Group 1 vs. Group 2 
  irrespective of Surgical Technique 
 
Of the 60 patients 48.33 % (n = 29) fell in group 1 and 51.67 % (n = 31) in group 2 
(Table 4.6).  The median value for group 1 was 68.68 and differs significantly from 
group 2 with a median value of 63.40 (Table 4.6). 
 
In group 1, only 14% (n=4) of the patients had on-pump CABG surgery whereas 86% 
(n=25) received off-pump CABG surgery. In group 2, 84% (n=26) of the patients had 
on-pump CABG surgery and only 16% (n=5) of the patients received off-pump CABG 
surgery.  Therefore it is important to note that the majority of patients with reduced 
cerebral flow/oxygen delivery as reflected by cerebral NIRS, received on-pump 
CABG surgery (84% fell in group 2). 
 
Table 4.6 NIRS:  Group 1 vs. Group 2 irrespective of surgical technique 
NIRS GROUP 1 (n=29) GROUP 2 (n=31) 
p-
value 
    
Median 68.68 63.40 0.0004 
25th percentile 64.07 57.21 - 
75th percentile 71.47 65.53 - 
The continuous variables are given as median with 25th and 75th percentile. The p-values were calculated with t-test 
and the Kruskal-Wallis-Test. A p < 0.05 indicates statistical significance.  
 
4.3.2.2 Mini-mental State Examination (MMSE): Group 1 vs. 
Group 2 irrespective of Surgical Technique 
 
No significant differences between the two groups were found in regard to pre- and 
post-operative MMSE.  Pre-operatively Group 2 showed a lower 25th percentile of 
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24.00 in comparison to Group 1's 27.  However, post-operatively the 25th percentile 
for Group 2 were 23 versus the 25 in Group 1 (Table 4.7).  Due to pre-operative 
sedation medication and refusal of the patients to take the test, not all of the 
patients that participated in the study have a pre- and post-operative MMSE. The 
patients that did not participate in the MMSE was not excluded from the study. 
 
Table 4.7 MMSE: Group 1 vs. Group 2 irrespective of surgical technique  
 
 GROUP 1 
 
GROUP 2 
p-
VALUE 
N Median 
25TH 
percentile 
75TH 
percentile 
n Median 
25TH 
percentile 
75TH 
percentile 
        
Pre 21 28.00 27.00 29.00 26 28.00 24.00 29.00 0.6320 
Post 19 28.00 25.00 30.00 25 26.00 23.00 28.00 0.1505 
Diff 19 0 -1.00 2.00 25 1.00 0 1.00 0.3207 
Interpretation of data (Normal – any score above 27 out of 30; Some cognitive impairment – a score between 20 
and 26 out of 30 and Moderate to severe cognitive impairment – a score between 10 and 19). The continuous 
variables are given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. A p < 0.05 indicates statistical significance. [Pre: pre-operative MMSE; Post: post-operative MMSE; Diff: 
difference between pre-operative MMSE and post-operative MMSE]. 
 
4.3.2.3 Renal Function: Group 1 and Group 2 irrespective of 
Surgical Technique 
 
Figure 4.2 - 4.13 illustrates the renal function reflected by the U&E, creatinine and 
urine output for the patients that fell in group 1 and the patients that fell in group 2 
irrespective of surgical technique. 
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Figure 4.2 Sodium for Cerebral NIRS Group 1 irrespective of surgical technique 
 
 
 
 
 
 
Figure 4.3 Sodium for Cerebral NIRS Group 2 irrespective of surgical technique 
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Figure 4.4 Chloride  for Cerebral NIRS Group 1 irrespective of surgical technique 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Chloride for Cerebral NIRS Group 2 irrespective of surgical technique 
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Figure 4.6 Potassium for Cerebral NIRS Group 1 irrespective of surgical technique 
 
 
 
Figure 4.7 Potassium for Cerebral NIRS Group 2 irrespective of surgical technique 
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Figure 4.8 Creatinine for Cerebral NIRS Group 1 irrespective of surgical technique 
 
 
 
 
Figure 4.9 Creatinine for Cerebral NIRS Group 2 irrespective of surgical technique 
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Figure 4.10 Urea for Cerebral NIRS Group 1 irrespective of surgical technique 
 
 
 
 
 
 
Figure 4.11 Urea for Cerebral NIRS Group 2 irrespective of surgical technique 
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Figure 4.12 Urine Output for Cerebral NIRS Group 1 irrespective of surgical 
technique 
 
 
 
Figure 4.13 Urine Output for Cerebral NIRS Group 2 irrespective of surgical 
technique 
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4.3.2.4 Renal Function: Group 1 vs. Group 2 irrespective of 
Surgical Technique 
 
In comparison the overall U&E and creatinine values of the two groups showed no 
statistical significant differences for potassium and chloride at baseline level, day 1, 
day 2 and day 3 respectively (Table 4.8). There was a statistical significant difference 
for sodium (Table 4.8) between group 1 and group 2 on day 2 (p = 0.0486). 
 
Table 4.8 Renal function: Group 1 vs. Group 2 irrespective of surgical technique 
U&E, CREATININE, 
URINE OUTPUT 
GROUP 1 
(n = 29) 
GROUP 2 
(n=31) 
 
p-VALUE 
Min/Max  Min/Max  
Sodium (mEq/L)    
Baseline 135/145 130/145 0.6921 
Day 0 135/152 135/151 0.2744 
Day 1 139/152 129/148 0.1749 
Day 2 133/144 130/148 0.0486 
Day 3 131/145 131/146 0.0572 
Potassium (mEq/L)    
Baseline 2.5/4.8 3.1/4.9 0.5577 
Day 0 2.7/4.9 2.7/8.8 0.2327 
Day 1 3.6/6.4 3.8/5.6 0.8916 
Day 2 3.7/5.2 3.8/5.1 0.1356 
Day 3 3.6/5.2 3.2/4.7 0.6566 
Chloride (mEq/L)    
Baseline 102/117 95/112 0.4107 
Day 0 102/118 102/116 0.2125 
Day 1 100/115 101/119 0.0998 
Day 2 103/115 100/116 0.3010 
Day 3 100/112 98/117 0.3514 
Urea (mEq/L)    
Baseline 1.6/7.4 2.8/9.4 0.7842 
Day 0 2.2/6.4 2.7/7.1 0.1690 
Day 1 1.7/9.1 3.0/11.5 0.1124 
Day 2 1.5/11.6 2.9/17.6 0.0263 
Day 3 2.8/12.4 2.7/20.5 0.3290 
Creatinine (mEq/L)    
Baseline 63/131 54/148 0.5008 
Day 0 67/151 62/138 0.5649 
Day 1 71/157 42/204 0.1867 
Day 2 66/176 52/230 0.3856 
Day 3 65/199 40/217 0.8726 
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Urine Output (ml/kg/hr)    
Intra-operative 0.58/15.69 0.39/8.09 0.1179 
0 hours 0.4/6.4 0.6/11.76 0.9925 
6 hours 0.65/2.86 0.68/3.12 0.4280 
12 hours 0.67/2.63 0.54/3.35 0.3172 
18 hours 0.37/2.27 0.46/4.16 0.1087 
24hours 0.22/2.76 0.51/2.84 0.0108 
30 hours 0.48/3.58 0.36/3.25 0.3451 
36 hours 0.73/5.21 0.48/2.74 0.5658 
42 hours 0.8/3.68 0.71/3.33 0.8200 
48 hours 0.59/2.66 0.55/2.6 0.5658 
54 hours 0.69/1.51 0.33/3.2 0.7952 
60 hours 0.68/3.17 0.33/3.36 0.9224 
The data was given as median with 25th and 75th percentile. The p-values were calculated with t-test and the 
Kruskal-Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were 
calculated with Chi-square test. A p < 0.05 indicates statistical significance. [mEq/L = mill equivalents per litre; 
ml/kg/hr- millilitres per kilogram per hour] 
 
On day 2, the urea values between the 2 groups indicated a statistical significant 
difference (p=0.0263). Urine output was evaluated in ml/kg/hour, and showed a 
statistical significant difference at 24 hours between group 1 and group 2 (p = 
0.0108). These differences showed that a NIRS reduction of more than 20 % from 
baseline and values of less than 50, did have an impact on post–operative renal 
function. The median value however was 63 (Table 4.8) The elevated urea value, 
with higher sodium and urine output might reflect a polyuric phase of early renal 
dysfunction. The creatinine values were however not different between the groups. 
The results  demonstrated a weak association and therefore this warrants further 
investigation. 
 
4.3.2.5 Post-operative Complications and Outcomes: Group 1 
 vs. Group 2 irrespective of Surgical Technique 
 
The mortality rate in the study was very low, only two patients died in group 1 (6.90%) 
and no mortality was reported in group 2 (0%).  The first patient was a 59-year-old 
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white male who underwent off-pump CABG surgery. According to his EuroSCORE 
(1.56%) he was a low-risk patient. After a stable intra-operative and early post-
operative course, the patient developed unexplained Acute Respiratory Distress 
Syndrome (ARDS). He died 96h post-operatively in the ICU due to untreatable 
respiratory failure. The second patient was an 80-year-old male who also underwent 
off-pump CABG surgery. The patient had a logistic EuroSCORE predicted risk 
percentage of 10.99% (high-risk patient). The patient developed post-operative 
kidney failure, respiratory failure, and pump failure with dysrythmia. The patient died 
after six days in the ICU due to multiple-organ failure and septic shock. 
 
Table 4.9 Post-operative Outcomes and Complications: Group 1 vs. Group 2 
irrespective of Surgical Technique 
OUTCOME VARIABLES 
GROUP 1 
(n=29) 
GROUP 2 
(n=31) 
p-VALUE 
Mortality    
Yes 2 (6.90%) - 
0.2294 
No 27 (93.10%) 31 (100%) 
Return to ICU    
Yes 1 (3.45%) - 
0.4833 
No 28 (96.55%) 31 (100%) 
Re-intubation    
Yes - 1 (3.23%) 
1.000 
No 29 (100%) 30 (96.77) 
Re-operation    
Yes 1 (3.45%) 1 (3.32%) 
1.000 
No 28 (96.55%) 30 (96.77%) 
Post-operative MI    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Pulmonary complications    
Yes - 2 (6.45%) 
0.4921 
No 29 (100%) 29 (93.55%) 
Neurological complications    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Renal complications    
Yes 1 (3.45%) - 
0.4833 
No 28 (96.55%) 31 (100%) 
GIT complications    
Yes 1 (3.45%) 1 (3.32%) 
1.000 
No 28 (96.55%) 30 (96.77%) 
Multi system failure    
Yes 1 (3.45%) - 0.4833 
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No 28 (96.55%) 31 (100%) 
Post-operative dissection of major arteries  
Yes - - 
- 
No 29 (100%) 31 (100%) 
Acute limb ischemia    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Heart block    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Atrial fibrillation    
Yes 1 (3.45%) 1 (3.32%) 
1.000 
No 28 (96.55%) 30 (96.77%) 
Cardiac arrest    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Anticoagulant complications    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Tamponade    
Yes - - 
- 
No 29 (100%) 31 (100%) 
Sternal wound infection    
Yes - 1 (3.23%) 
1.000 
No 29 (100%) 30 (96.77) 
Septicaemia    
Yes 1 (3.45%) 1 (3.32%) 
1.000 
No 28 (96.55%) 30 (96.77%) 
Post-operative blood transfusion   
Yes 7 (24.14%) 14 (45.16%) 
0.1369 
No 21 (72.41%) 17 (54.84%) 
Length of hospital stay (days)    
Median 8.00 8.00 0.5111 
25th percentile 6.00 7.00 - 
75th percentile 11.00 10.00 - 
Length of ICU stay (days)    
Median 3.00 3.00 0.3029 
25th percentile 2.00 3.00 - 
75th percentile 3.00 3.00 - 
Ventilation time (hours)    
Median 10.00 12.00 0.0099 
25th percentile 6.00 12.00 - 
75th percentile 14.00 16.00 - 
The data is given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were calculated 
with Chi-square test.  A p < 0.05 indicates statistical significance. [MI: Myocardial infarction; ICU: Intensive Care Unit; 
GIT: Gastro-intestinal system]. 
 
Two patients in group 2 had pulmonary complications (6.45%) and none in group 1 
(0%) respectively. One patient in each group presented with gastro-intestinal 
complications, atrial fibrillation, and septicaemia. None of the patients presented 
with post-operative myocardial infarction, neurological complications, acute limb 
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ischemia, heart block, cardiac arrest, anticoagulant complications, tamponade, or 
dissection of the major arteries (Table 4.9). 
Most importantly, no statistical significant difference were found between the 2 
groups in regards to length of hospital stay (p = 0.5111) and length of ICU stay (p = 
0.3029). However, ventilation time showed a statistical significant difference 
between the 2 groups (p-value = 0.0099), demonstrating a 2 hour longer post-
operative ventilation time in group 2 (Table 4.9). 
 
4.3.3 Comparison of Cerebral NIRS values between Group 1 (rSO2 > 
 50; < 20% drop from baseline value) & Group 2 (rSO2 ≤ 50; > 20% drop 
 from baseline value) in patients receiving On-Pump CABG surgery 
 (Analysis 3) 
 
All on-pump CABG patients (n = 30) were subdivided into 2 cerebral NIRS groups 
(group 1 = rSO2 > 50; < 20% from baseline value and group 2 = rSO2 ≤ 50; > 20% from 
baseline value). These groups were then compared with the MMSE (Table 4.10), 
intra-operative hemodynamic data (Table 4.11), renal function (Figure 4.14 – 4.25 
and Table 4.12), and all other post-operative complications/outcomes (Table 4.13).  
 
Thirty patients received on-pump CABG surgery of which 13.33% (n = 4) fell in group 
1 and 86.67% (n = 26) in group 2. Therefore, it is important to note that 86.67% of on-
pump patients had reduced or compromised cerebral blood flow, as reflected in 
reductions in cerebral NIRS values of more than 20%, or absolute values of less than 
50. 
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4.3.3.1 Mini-Mental State Examination (MMSE): Group 1 vs. 
Group 2 (on-pump CABG surgery) 
 
No statistical significant differences were found in pre- and post-operative MMSE 
between the two groups that received on-pump CABG surgery (Table 4.10). The 
number of patients that received the MMSE pre-operatively in group 1 was 75% (n=3) 
and in group 2 were 80.76% (n=21).  Post-operatively 75% (n=3) in group 1 received 
the MMSE and 76.92% (n=20) in group 2.  The difference in numbers are ascribe to 
patients refusing to take the test and if the patient already received his/her pre-
operative medication the test was also not performed (patients were not excluded 
due to this reason). However, by interpreting the existing data the reduction in 
cerebral NIRS values were not linked to adverse neurological outcomes (the median 
scores were equal or above 27 for both group 1 and group 2 which indicates normal 
neurological function). 
 
Table 4.10 MMSE: Group 1 vs. Group 2 (on-pump CABG surgery) 
 
 GROUP 1 
 
GROUP 2 
p-
VALUE 
n median 
25th 
percentile 
75th 
percentile 
n median 
25th 
percentile 
75th 
percentile 
        
Pre 3 29.00 29.00 30.00 21 28.00 24.00 29.00 0.1419 
Post 3 29.00 24.00 30.00 20 26.50 23.50 28.50 0.4078 
Diff 3 0 0 5.00 20 1.00 0 1.50 0.8516 
Interpretation of data (Normal – any score above 27 out of 30; Some cognitive impairment – a score between 20 
and 26 out of 30 and Moderate to severe cognitive impairment – a score between 10 and 19). The continuous 
variables are given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. A p < 0.05 indicates statistical significance. [Pre: pre-operative MMSE; Post: post-operative MMSE; Diff: 
difference between pre-operative MMSE and post-operative MMSE]. 
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4.3.3.2 Intra-operative Hemodynamic Monitoring: Group 1 vs. 
Group 2 (on-pump CABG surgery) 
 
Intra-operative observations of heart rate, mean arterial pressure, systolic pressure, 
cardiac output, haemoglobin concentration, oxygen saturation (O2SAT), and partial 
pressure of oxygen (pO2) were recorded for every patient that received a NIRS 
analysis. These observations revealed no statistical significant difference between 
group 1 and group 2 (Table 4.11). This table clearly demonstrates the limitation of 
hemodynamic data in detecting subtle changes in tissue perfusion compared to 
cerebral NIRS values and trends. 
 
Table 4.11 Intra-operative Hemodynamic Data: Group 1 vs. Group 2 (on-pump 
CABG surgery) 
INTRA-OPRATIVE DATA 
GROUP 1 
(n=4) 
GROUP 2 
(n=26) 
p-
VALUE 
Heart Rate (beats/min)    
Median 62.50 69.00 0.3756 
25th percentile 62.00 63.00 - 
75th percentile 74.50 84.00 - 
Mean Arterial Pressure (mmHg)    
Median 85.135 94.535 0.6255 
25th percentile 80.045 71.84 - 
75th percentile 98.35 119.38 - 
Systolic Pressure (mmHg)    
Median 123.49 131.81 0.9514 
25th percentile 117.31 100.56 - 
75th percentile 148.325 145.90 - 
Cardiac Output (l/min)    
Median 4.705 4.84 0.7518 
25th percentile 4.345 4.34 - 
75th percentile 5.185 5.09 - 
Haemoglobin (kPa)    
Median 13.35 14.55 0.3758 
25th percentile 12.40 13.90 - 
75th percentile 15.55 15.40 - 
O2SAT (%)    
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Median 95.10 95.50 0.6672 
25th percentile 94.60 93.80 - 
75th percentile 98.10 96.10 - 
pO2 (kPa)    
Median 89.80 71.15 0.4456 
25th percentile 67.95 64.90 - 
75th percentile 162.05 77.70 - 
The data is given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. A p < 0.05 indicates statistical significance. [O2SAT: Oxygen Saturation; PO2: Partial Pressure of Oxygen; 
min: minute; mmHg: millimetres mercury; l/min: litres per minute; %: percentage; kPa: kilopascal]. 
 
 
4.3.3.3 Renal Function: Group 1 vs. Group 2 (on-pump CABG 
surgery) 
 
No statistical significant differences were found between the two groups with 
reference to sodium, urea, and urine output (Table 4.12). However, the statistical 
significant difference in creatinine [day 1 (p = 0.0398)] showed that a NIRS reduction 
of more than 20 % in baseline and values of less than 50, did have an association 
with post–operative renal function. 
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Figure 4.14 Sodium for Cerebral NIRS Group 1 (on-pump CABG surgery) 
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Figure 4.15 Sodium for Cerebral NIRS Group 2 (on-pump CABG surgery) 
 
Figure 4.16 Chloride for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
 
 
 
Figure 4.17 Chloride for Cerebral NIRS Group 2 (on-pump CABG surgery) 
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Figure 4.18 Potassium for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
 
 
 
Figure 4.19 Potassium for Cerebral NIRS Group 2 (on-pump CABG surgery) 
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Figure 4.20 Urea for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
 
 
Figure 4.21 Urea  for Cerebral NIRS Group 2 (on-pump CABG surgery) 
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Figure 4.22 Creatinine for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
 
Figure 4.23 Creatinine for Cerebral NIRS Group 2 (on-pump CABG surgery) 
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Figure 4.3.3.11: Group 1 U&E Urine Output values 
 
 
Figure 4.24 Urine Output for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
Figure 4.25 Urine output for Cerebral NIRS Group 2 (on-pump CABG surgery) 
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Table 4.12 Renal Function: Group 1 vs. Group 2 (on-pump CABG surgery) 
U&E, CREATININE, URINE 
OUTPUT 
GROUP 1 
(n=4) 
GROUP 2 
(n=26) p-VALUE 
Min/Max Min/Max 
Sodium (mEq/L)    
Baseline 135/145 135/145 0.8058 
Day 0 136/146 136/151 0.3404 
Day 1 135/139 129/148 0.2092 
Day 2 134/139 131/148 0.7991 
Day 3 133/137 131/146 0.8653 
Potassium (mEq/L)    
Baseline 2.5/3.9 3.1/4.9 0.0089 
Day 0 3.1/4.9 2.7/8.8 0.4615 
Day 1 4.3/4.8 3.8/5.6 0.2088 
Day 2 4.0/4.4 3.8/5.0 0.0559 
Day 3 3.6/4.2 3.8/4.7 0.3111 
Chloride (mEq/L)    
Baseline 102/107 102/112 0.2697 
Day 0 105/118 102/116 0.9510 
Day 1 107/115 101/119 1.000 
Day 2 104/112 103/116 0.8860 
Day 3 103/110 98/117 0.7007 
Urea (mEq/L)    
Baseline 3.7/6.5 2.8/9.4 0.7835 
Day 0 4.0/5.2 2.7/7.1 0.8546 
Day 1 3.9/5.7 3.5/11.5 0.1210 
Day 2 3.5/8.2 3.2/17.6 0.2291 
Day 3 5.1/8.3 3.3/20.5 0.7061 
Creatinine (mEq/L)    
Baseline 68/125 76/137 0.3138 
Day 0 82/131 79/138 0.2459 
Day 1 71/104 74/204 0.0398 
Day 2 66/97 66/230 0.1944 
Day 3 70/91 54/217 0.4513 
Urine Output (ml/kg/hr)    
Intra-operative 2.79/15.69 0.39/8.09 0.2001 
0 hours 1.02/1.66 0.60/11.76 0.4127 
6 hours 1.15/2.18 0.68/3.12 0.7329 
12 hours 1.11/1.80 0.60/3.35 0.4528 
18 hours 1.08/1.71 0.46/4.16 0.4528 
24hours 1.11/2.58 0.97/2.84 0.3393 
30 hours 0.75/3.58 1.04/3.25 0.7329 
36 hours 1.04/2.63 0.83/2.74 0.7848 
42 hours 1.09/2.67 0.83/3.33 0.8312 
48 hours 0.59/1.66 0.55/2.60 0.2712 
54 hours 1.08/1.82 0.63/3.20 0.4730 
60 hours 1.02/2.22 0.62/3.36 0.8110 
The data was given as median with 25th and 75th percentile. The p-values were calculated with t-test and the 
Kruskal-Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were 
calculated with Chi-square test. A p < 0.05 indicates statistical significance. [mEq/L: mill equivalents per litre; ml/ kg/ 
hr: millilitres per kilogram per hour] 
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4.3.3.4 Post-operative Complications/Outcomes: Group 1 vs. 
Group 2 (on-pump CABG surgery) 
 
The patients in group 1 had no post-operative complications. The post-operative 
complications reported for group 2 were: re-intubation 3.85% (n=1), pulmonary 
complications 3.58% (n=1), GIT complications 3.58% (n=1), atrial fibrillation 3.58% 
(n=1), sternal wound infection 3.58% (n=1), and septicaemia 3.58% (n=1). Seventy 
five percent (n=3) of patients in group 1 had a post-operative blood transfusion and 
50% (n=13) in group 2. Because of the small sample size in group 1, statistical analysis 
is senseless and therefore data is displayed in a frequency table (Table 4.13). 
 
Table 4.13 Post-operative Outcomes and Complications: Group 1 vs. Group 2 (on-
 pump CABG surgery) 
OUTCOME VARIABLES 
GROUP 1 
(n=4) 
GROUP 2 
(n=26) 
Mortality   
Yes - - 
No 4 (100%) 26 (100%) 
Return to ICU   
Yes - - 
No 4 (100%) 26 (100%) 
Re-intubation   
Yes - 1 (3.85%) 
No 4 (100%) 25 (96.15%) 
Re-operation   
Yes - 1 (3.85%) 
No 4 (100%) 26 (100%) 
Post-operative MI   
Yes - - 
No 4 (100%) 26 (100%) 
Pulmonary complications   
Yes - 1 (3.85%) 
No 4 (100%) 25 (96.15%) 
Neurological complications   
Yes - - 
No 4 (100%) 26 (100%) 
Renal complications   
Yes - - 
No 4 (100%) 26 (100%) 
GIT complications   
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Yes - 1 (3.85%) 
No 4 (100%) 25 (96.15%) 
Multi system failure   
Yes - - 
No 4 (100%) 26 (100%) 
Post-operative dissection of major arteries  
Yes - - 
No 4 (100%) 26 (100%) 
Acute limb ischemia   
Yes - - 
No 4 (100%) 26 (100%) 
Heart block   
Yes - - 
No 4 (100%) 26 (100%) 
Atrial fibrillation   
Yes - 1 (3.85%) 
No 4 (100%) 25 (96.15%) 
Cardiac arrest   
Yes - - 
No 4 (100%) 26 (100%) 
Anticoagulant complications   
Yes - - 
No 4 (100%) 26 (100%) 
Tamponade   
Yes - - 
No 4 (100%) 26 (100%) 
Sternal wound infection   
Yes - 1 (3.85%) 
No: 4 (100%) 25 (96.15%) 
Septicaemia   
Yes - 1 (3.85%) 
No 4 (100%) 25 (96.15%) 
Post-operative blood transfusion  
Yes 3 (75.00%) 13 (50.00%) 
No 1 (25.00%) 13 (50.00%) 
Length of hospital stay (days)   
Median 8.00 8.00 
25th percentile 6.50 7.00 
75th percentile 10.00 12.00 
Length of ICU stay (days)   
Median 3.00 3.00 
25th percentile 2.50 3.00 
75th percentile 3.50 3.00 
Ventilation time (hours)   
Median 13.00 12.00 
25th percentile 10.00 12.00 
75th percentile 14.00 16.00 
The data is given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were calculated 
with Chi-square test. A p < 0.05 indicates statistical significance. [MI: Myocardial infarction; ICU: Intensive Care Unit; 
GIT: Gastro-intestinal system]. 
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4.3.4 Comparison of Cerebral NIRS values between Group 1 (rSO2 > 
 50; < 20% drop from baseline value) & Group 2 (rSO2 ≤ 50; >  20% drop 
from baseline value) in patients receiving Off-Pump CABG surgery 
(Analysis 4) 
 
In analysis 4 all off-pump CABG patients (n=30) were subdivided into two cerebral 
NIRS groups (group 1 = rSO2 > 50; < 20% from baseline value and group 2 = rSO2 ≤ 50; 
> 20% from baseline value).  The cerebral NIRS values of the two groups were then 
compared with MMSE (Table 4.14), intra-operative hemodynamic data (Table 4.15), 
renal function (Figure 4.26 - 4.37; Table 4.16), and all other post-operative 
complications/outcomes (Table 4.17). Thirty patients received off-pump CABG 
surgery of which 83.33% (n=25) fell in group 1 and 16.67% (n = 5) in group 2. It is 
important to note that 83.33% of patients undergoing off-pump surgery, had 
satisfactory NIRS values. 
 
4.3.4.1 Mini-Mental State Examination (MMSE): Group 1 vs. 
Group 2 (off-pump CABG surgery) 
 
Again, no statistical significant differences were found in the pre- and post-operative 
MMSE between the 2 groups of the patients that received off-pump CABG surgery 
(Table 4.14). The number of patients that received the MMSE pre-operatively in 
group 1 was 72% (n=18) and in group 2 were 100% (n=5). Post-operatively 64% (n=16) 
in group 1 received MMSE and 100% (n=5) in group 2.  The difference in numbers are 
ascribe to pre-operative sedation medication and refusal of the patients to take the 
test. 
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Table 4.14 MMSE: Group 1 vs. Group 2 (off-pump CABG surgery) 
 
 GROUP 1  GROUP 2 
p-
VALUE N median 
25th 
percentile 
75th 
percentile 
n median 
25th 
percentile 
75th 
percentile 
        
Pre 18 28.00 27.00 29.00 5 29.00 24.00 29.00 0.8785 
Post 16 28.00 25.50 29.50 5 25.00 23.00 28.00 0.1905 
Diff 16 0 -1.5 1.50 5 4.00 1.00 1.00 0.2218 
The continuous variables are given as median with 25th and 75th percentile. The p-values were calculated with t-test 
and the Kruskal-Wallis-Test. A p < 0.05 indicates statistical significance. Pre: pre-operative MMSE; Post: post-operative 
MMSE; Diff: difference between pre-operative MMSE and post-operative MMSE. 
 
4.3.4.2 Intra-operative Hemodynamic Monitoring: Group 1 vs.  
Group 2 (off-pump CABG surgery) 
 
The intra-operative hemodynamic data displayed no statistical significant 
differences between the two groups receiving off-pump CABG surgery (Table 4.15). 
 
 
 
 
 
 
 
 
 
CHAPTER 4: RESULTS 
 
118 
Table 4.15 Intra-operative Hemodynamic Data: Group 1 vs. Group 2 (off-pump 
CABG surgery) 
VARIABLES 
GROUP 1 
(n=25) 
GROUP 2 
(n=5) 
p- 
value 
Heart Rate (beats/min) n=24   
Median 68.00 69.00 0.6645 
25th percentile 59.50 68.00 - 
75th percentile 76.00 72.00 - 
Mean Arterial Pressure (mmHg) n=24   
Median 101.195 81.59 0.5637 
25th percentile 79.43 80.53 - 
75th percentile 123.49 106.10 - 
Systolic Pressure (mmHg) n=24   
Median 142.53 125.44 0.4884 
25th percentile 109.855 121.31 - 
75th percentile 174.30 161.71 - 
Haemoglobin (kPa)    
Median 13.70 12.30 0.4519 
25th percentile 12.50 12.30 - 
75th percentile 14.90 12.60 - 
O2SAT (%)    
Median 95.00 95.50 0.7595 
25th percentile 93.90 93.20 - 
75th percentile 96.60 97.00 - 
pO2 (kPa)    
Median 71.80 69.30 0.5222 
25th percentile 66.70 61.30 - 
75th percentile 107.30 126.10 - 
The data is given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. A p < 0.05 indicates statistical significance. [min: minute; mmHg: millimetres mercury; kPa: kilopascal; 
O2SAT: Oxygen Saturation; %: percentage  PO2: Partial Pressure of Oxygen] 
 
 
4.3.4.3 Renal Function: Group 1 vs. Group 2 (off-pump CABG 
surgery) 
 
No statistical significant differences were seen between group 1 and 2 with 
reference to potassium, urea and creatinine for the patients that received off-pump 
CABG surgery (Table 4.16). 
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Figure 4.26 Sodium for Cerebral NIRS Group 1(off-pump CABG surgery) 
 
 
 
 
   
Figure 4.27 Sodium for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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Figure 4.28 Chloride for Cerebral NIRS Group 1 (off-pump CABG surgery) 
 
 
 
Figure 4.29 Chloride for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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Figure 4.30 Potassium for Cerebral NIRS Group 1 (off-pump CABG surgery) 
 
 
Figure 4.31 Potassium for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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Figure 4.32 Urea for Cerebral NIRS Group 1 (off-pump CABG surgery) 
 
 
 
 
Figure 4.33 Urea for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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Figure 4.34 Creatinine for Cerebral NIRS Group 1 (on-pump CABG surgery) 
 
 
 
 
 
Figure 4.35 Creatinine for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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Figure 4.36 Urine output for Cerebral NIRS Group 1 (off-pump CABG surgery) 
 
 
Figure 4.37 Urine output for Cerebral NIRS Group 2 (off-pump CABG surgery) 
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The increased urine output at 12 hrs (p=0.0440), 42 hrs (p=0.0064) and 48hrs 
(p=0.0357) post-operatively might once again reflect a period of polyurea 
secondary to impaired renal flow, but the creatinine values showed no difference 
(Table 4.3.4.3). It might also reflect mobilization of sequestrated fluid post-
operatively. 
 
Table 4.16 Renal Function: Group 1 vs. Group 2 (off-pump CABG surgery) 
U&E, CREATININE, URINE 
OUTPUT 
GROUP 1 
(n=25) 
GROUP 2 
(n=5) p-VALUE 
Min/Max  Min/Max  
Sodium (mEq/L)    
Baseline 136/144 130/139 0.1647 
Day 0 135/152 135/141 0.1593 
Day 1 130/152 132/139 0.3018 
Day 2 133/144 130/135 0.0057 
Day 3 131/145 131/137 0.0661 
Potassium (mEq/L)    
Baseline 3.3/4.8 3.6/4.5 0.1984 
Day 0 2.7/4.8 4.0/4.5 0.2044 
Day 1 3.6/6.4 3.9/5.3 0.8640 
Day 2 3.7/5.2 4.1/5.1 0.6811 
Day 3 3.8/5.2 3.2/4.2 0.3094 
Chloride (mEq/L)    
Baseline 102/117 95/106 0.0250 
Day 0 102/118 108/116 0.4634 
Day 1 100/114 106/112 0.5825 
Day 2 103/115 100/107 0.0517 
Day 3 100/112 101/108 0.7550 
Urea (mEq/L)    
Baseline 1.6/7.4 3.7/8.9 0.6359 
Day 0 2.2/6.4 4.2/6.9 0.0941 
Day 1 1.7/9.1 3.0/8.5 0.8377 
Day 2 1.5/11.6 2.9/9.9 0.7385 
Day 3 2.8/12.4 2.7/8.6 0.7364 
Creatinine (mEq/L)    
Baseline 63/131 54/148 0.7807 
Day 0 67/151 62/133 0.6820 
Day 1 71/157 42/132 0.6820 
Day 2 67/176 52/134 0.7108 
Day 3 65/199 40/132 0.5449 
Urine Output (ml/kg/hr)    
Intra-operative 0.58/5.58 0.54/3.86 0.8625 
0 hours 0.40/6.40 0.90/1.78 0.3526 
6 hours 0.65/2.86 0.85/1.72 0.3139 
12 hours 0.67/2.63 0.54/1.07 0.0440 
18 hours 0.37/2.27 0.92/2.34 0.6421 
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24hours 0.22/2.76 0.51/1.60 0.3139 
30 hours 0.48/2.43 0.36/1.83 0.0744 
36 hours 0.73/5.21 0.48/2.06 0.0744 
42 hours 0.80/3.62 0.71/0.94 0.0064 
48 hours 0.80/2.66 0.73/1.40 0.0357 
54 hours 0.69/3.12 0.33/2.03 0.3918 
60 hours 0.68/3.17 0.33/2.23 0.4835 
The data was given as median with 25th and 75th percentile. The p-values were calculated with t-test and the 
Kruskal-Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were 
calculated with Chi-square test. A p < 0.05 indicates statistical significance. [mEq/L: mill equivalents per litre; 
ml/kg/hr: millilitre per kilogram per hour] 
 
4.3.4.4 Post-operative Complications/Outcomes: Group 1 vs.  
Group 2 (off-pump CABG surgery) 
 
Statistical analysis revealed no statistical differences in post-operative 
complications/outcomes between group 1(n=25) and group 2 (n=5) for patients that 
received off-pump CABG surgery (Table 4.17). 
 
The post-operative complications reported for group 1 were:  mortality rate 8% (n=2); 
re-admission to ICU 4% (n=1); re-operation 4% (n=1), renal complications 4% (n=1) 
and the same for gastro-intestinal complications, multi system failure, atrial fibrillation, 
and septicemia. Sixteen percent (n=4) of the patients in group 1 had a post-
operative blood transfusion. The number of complications for the patients that fell in 
group 2 was much less.  Only 20% (n=1) had post-operative pulmonary 
complications and 20% (n=1) had a blood transfusion after surgery. The ventilation 
times ranged from 6 to 9 hours in group 1 and 12 to 18 hours in group 2 with a 
borderline p-value of 0.0596. 
 
Because of the small sample size in group 2, a statistical analysis is senseless and 
therefore data is displayed in a frequency table (Table 4.17). 
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Table 4.17 Post-operative Outcomes and Complications: Group 1 vs. Group 2 (off-
pump CABG surgery) 
OUTCOME VARIABLES 
GROUP 1 
(n=25) 
GROUP 2 
(n=5) 
Mortality   
Yes 2 (8.00%) - 
No 23 (92.00%) 5 (100%) 
Return to ICU   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Re-intubation   
Yes - - 
No 25 (100%) 5 (100%) 
Re-operation   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Post-operative MI   
Yes - - 
No 25 (100%) 5 (100%) 
Pulmonary complications   
Yes - 1 (20.00%) 
No 25 (100%) 4 (80.00%) 
Neurological complications   
Yes - - 
No 25 (100%) 5 (100%) 
Renal complications   
Yes 1 (4.00%) - 
N 24 (96.00%) 5 (100%) 
GIT complications   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Multi system failure   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Post-operative dissection of major arteries   
Yes - - 
No 25 (100%) 5 (100%) 
Acute limb ischemia   
Yes - - 
No 25 (100%) 5 (100%) 
Heart block   
Yes - - 
No 25 (100%) 5 (100%) 
Atrial fibrillation   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Cardiac arrest   
Yes - - 
No 25 (100%) 5 (100%) 
Anticoagulant complications   
Yes - - 
No 25 (100%) 5 (100%) 
Tamponade   
Yes - - 
No 25 (100%) 5 (100%) 
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Sternal wound infection   
Yes - - 
No 25 (100%) 5 (100%) 
Septicaemia   
Yes 1 (4.00%) - 
No 24 (96.00%) 5 (100%) 
Post-operative blood transfusion  
Yes 4 (16.00%) 1 (20.00%) 
No 20 (80.00%) 4 (80.00%) 
Length of hospital stay (days)   
Median 8.00 7.00 
25th percentile 6.00 6.00 
75th percentile 11.00 8.00 
Length of ICU stay (days)   
Median 3.00 3.00 
25th percentile 2.00 3.00 
75th percentile 3.00 4.00 
Ventilation time (hours)   
Median 9.00 12.00 
25th percentile 6.00 12.00 
75th percentile 12.00 18.00 
The data is given as median with 25th and 75th percentile. The p-values were calculated with t-test and the Kruskal-
Wallis-Test. Categorical variables are demonstrated with an n-value and percentages. The p-values were calculated 
with Chi-square test.  A p < 0.05 indicates statistical significance. MI: Myocardial infarction; ICU: Intensive Care Unit; 
GIT: Gastro-intestinal system. 
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  5.1 INTRODUCTION 
 
The Somanetics® INVOS® Cerebral Oximeter presents a new “vital sign” called 
regional saturation of oxygen (rSO2). The system alerts clinicians of cerebral 
desaturation and gives an early warning of regional oxygen imbalances that may 
be encountered in surgery or in the cardiac laboratory. A decline in cerebral 
oximeter values, during CPB, occurs frequently in cardiac surgery and reflect the 
changing hemodynamic profile of balance between brain oxygen delivery and 
consumption. Since low rSO2 values correlate with adverse neurological outcome, 
continuous assessment via cerebral oximetry, using near-infrared spectroscopy, is a 
valuable patient management tool and low values can be corrected with simple 
interventions. 
 
A decline in rSO2 below 50, or a decline of more than 20 percent from baseline is 
cause for concern and warrants the initiation of intervention.  Absolute values, 
below 40 and a drop of more than 25 percent from baseline, are associated with 
neurological dysfunction and other adverse outcomes.  A rSO2 < 50 or drop of 25% 
from baseline are linked to cerebral hypoperfusion and is associated with post-
operative neurological dysfunction. In this study the cerebral values were interpreted 
using the threshold values of rSO2 >50 or < 20% drop from baseline and rSO2 < 50 or > 
25% drop from baseline as published by Edmonds and co-workers, (2004). 
 Chapter 5 
DISCUSSION 
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  5.2 PRE-OPERATIVE DEMOGRAPHIC AND CLINICAL DATA  
(ON-PUMP VERSUS OFF-PUMP) 
 
Essentially the patients in the on-pump and off-pump groups were considered to be 
similar regarding risk factors and co-morbidities.  No differences could be 
demonstrated between the on-pump and off-pump group with regard to pre-
operative demographics.  The only difference between the groups was the amount 
of pre-operative acute MI's [on-pump (n=14; 47%) versus off-pump (n=22; 73%)].  
Therefore, we conclude that the study population was similar in nature with no clear 
distinguishable factors between the on-pump and off-pump groups. 
 
The pre-operative Mini-mental State examination showed no difference between 
the two groups and no cognitive impairment could be demonstrated using either 
technique.  Both the on-pump and off-pump group had a median value above 27. 
It was very difficult to accurately interpret the data due to patients refusing to take 
the test, educational level, and pre-operative medication. Another factor that could 
contribute was the fact that the examination was done by a perfusionist and not a 
qualified occupational therapist with professional interview and interpretation skills.  
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  5.3 CEREBRAL NIRS PERFORMED ON ON-PUMP AND OFF-PUMP 
 CABG GROUPS (ANALYSIS 1) 
 
5.3.1  Cerebral Near Infrared Spectroscopy (NIRS)  
 
It is clear from the results that patients that received on-pump CABG surgery had 
more compromised (compromised = rSO2 <50; ≥ 20% drop from baseline) cerebral 
flow than those patients that received off-pump CABG surgery. In the on-pump 
group 86.87% (n=26) had compromised cerebral blood flow and only 16.67% (n=5) in 
the off-pump group had compromised cerebral blood flow.  It is important to note 
that of all cerebral NIRS vales recorded the lowest NIRS value of each patient was 
used for data analysis in both the on-pump and off-pump groups.  The median 
values between the on-pump and off-pump were 69 and 65.5 respectively with no 
statistical significant difference between the two groups (p=0.3398).   
 
5.3.2 Cerebral NIRS linked to intra-operative events (on-pump 
versus off-pump) 
 
The cerebral NIRS values of the on-pump and off-pump groups were linked to pre-
determined intra-operative events in order to reflect the hemodynamic impact of 
events during these procedures on oxygen delivery (as reflected in NIRS values). 
While events are non-comparable between groups, time lines were used and 
median values were compared between on and off-pump groups.  No statistical 
significant difference could be demonstrated between the time lines (events) 
between the on-pump and off-pump groups. 
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  5.4 COMPARISON OF CEREBRAL NIRS VALUES BETWEEN GROUP 1 
( rSO2= ≥ 50, < 20% drop from baseline value) AND GROUP 2 (rSO2 < 50, > 
20% drop from baseline value) IRRESPECTIVE OF SURGICAL 
TECHNIQUE (ANALYSIS 2) 
 
5.4.1  Cerebral Near Infrared Spectroscopy (NIRS)  
 
Of the 60 patients 29 patients fell in group 1 and 31 patients in group 2.  The NIRS 
values showed a statistical significant difference (p=0.0004) between group 1 and 
group 2. It is important to note that the majority of patients with reduced cerebral 
flow/oxygen delivery (group 2) as reflected in cerebral NIRS, had on-pump CABG 
procedures (84% of risk group 2). 
 
5.4.2  Mini-mental State Examination 
 
The cerebral NIRS values in group 1 was above 27 (median score 28, pre- and 
postoperative), therefore none of the patients in group 1 showed any cognitive 
decline after CABG surgery. On the other hand the median pre-operative score for 
group 2 was 28 but after CABG surgery it dropped to 26 indicative of mild cognitive 
impairment (Lopez et al., 2005).  This corresponds with the cerebral NIRS values 
because group 2 had compromised cerebral flow during surgery (rSO2 < 50, > 20% 
drop from baseline value). The MMSE revealed no statistical significant difference 
between the two groups.  
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5.4.3  Renal Function 
 
A statistical significant difference was found for urinary output (p=0.0108) on day 1 
and in sodium (p = 0.0486) and urea values (p=0.0263) on day 2 between the two 
groups. 
 
Group 2 had a higher sodium, urea and urinary output minimum maximum range 
than group 1.  Therefore, these differences show that a NIRS reduction of more than 
20 % in baseline and values of less than 50, with a median NIRS value of 63 can 
possibly be associated with a decline in post–operative renal function.  The elevated 
urea value, with higher sodium and urine output might reflect a polyuric phase of 
early renal dysfunction. The creatinine values were however not different between 
the groups. 
 
The reason why the creatinine remained relatively stable could be attributed to the 
compensatory mechanism of the kidneys.  Serum creatinine level is a late indicator 
of renal injury. According to McBride and Skoyles (2004) a patient can lose up to 50% 
of his renal tubular function before his creatinine levels will start to decline. 
 
5.4.4  Post-operative Outcomes and Complications 
 
No major post-operative differences could be demonstrated between the two 
groups.  The only difference between the two groups was recorded for the 
ventilation time.  Although group 2 demonstrated longer post-operative ventilation 
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times (median group 2 = 12.00 versus median group 1 = 10.00) the median length of 
stay for group 1 and 2 was exactly the same (8 days). 
  5.5 COMPARISON OF CEREBRAL NIRS VALUES BETWEEN 
GROUP 1 (rSO2 > 50; < 20% drop from baseline value) & GROUP 2 
(rSO2 ≤ 50; > 20% drop from baseline value) IN PATIENTS RECEIVING 
ON-PUMP CABG SURGERY (ANALYSIS 3) 
 
5.5.1  Cerebral Near Infrared Spectroscopy (NIRS)  
 
All on-pump CABG patients (n=30) were subdivided into group 1 (satisfactory 
cerebral oxygenation) and group 2 (compromised cerebral oxygenation). Although 
median NIRS values were above 50, a total of 26 (86.67%) patients fell in group 2. It is 
important to take note that the times spend “under the curve” was restricted due to 
intervention by the perfusionist and anaesthesiologist. 
 
5.5.2  Mini-mental State Examination 
 
The MMSE results of Group 1 pre- and post-operatively were both 29 therefore no 
cognitive decline were present after surgery [score ≥ 27 = normal (Lopez et al., 
2005)].  However the number of patients that fell in group 1 was only 4 of which 3 
received MMSE pre- and post-operatively. 
 
Although group 2 had compromised cerebral blood flow (more than 20% drop from 
baseline) the MMSE scores were also ≥ 27. The decline in cerebral NIRS values in 
group 2 (pre-operatively = 28, post-operatively = 27) was not sufficient enough to 
cause cognitive impairment in these patients.  The MMSE revealed no difference 
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between the two groups (p>0.05) but factors as previously stated could have 
contributed to compromised data and should be taken into consideration. 
 
5.5.3  Renal Function 
 
A statistical significant difference was found for creatinine (p=0.0398) on day 1 and a 
statistical baseline difference for potassium (p = 0.0089). 
 
In Group 2 we found an increase in both urea and creatinine levels as well as a 
decrease in urine output post-operatively, which suggest that a NIRS reduction of 
more than 20 % in baseline and values of less than 50 during CABG surgery, with a 
minimum median NIRS value of 51 has no association with post–operative renal 
function. 
 
5.5.4  Post-operative Outcomes and Complications 
 
No major post-operative differences could be demonstrated between the two 
groups.  Due to small sample size in group 1, statistical data was counterintuitive.  
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  5.6 COMPARISON OF CEREBRAL NIRS VALUES BETWEEN 
GROUP 1 (rSO2 > 50; < 20% drop from baseline value) & GROUP 2 
(rSO2 ≤ 50; > 20% drop from baseline value) IN PATIENTS RECEIVING 
OFF-PUMP CABG SURGERY (ANALYSIS 4) 
 
5.6.1  Cerebral Near Infrared Spectroscopy (NIRS)  
 
All off-pump CABG patients (n=30) were subdivided into group 1 (satisfactory 
cerebral oxygenation) and group 2 (compromised cerebral oxygenation). Only 5 of 
these patients had a decrease in cerebral oxygen delivery (group 2) with a 
minimum median value of 52, therefore above 50, but had a more than 20% drop 
from the baseline value. 
 
5.6.2  Mini-mental State Examination 
 
The decline in cerebral NIRS values in the group 1 was not sufficient enough to cause 
cognitive impairment in these patients.  Both the median pre- and post-operative 
MMSE scores were above 27.  The patients in group 2 did display cognitive decline 
because the pre-operative score of 29 dropped to 25 post-operatively.  However 
only 5 patients fell in group 2.   
 
Pre- and post-operatively no statistical difference were found between group 1 and 
group 2 (p>0.05). 
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5.6.3  Renal Function 
 
In off-pump CABG patients, a statistical significant difference was found for sodium 
(p=0.0057)) on day 2 and in urine output (p = 0.0440, p = 0.0064, p = 0.0357 
respectively) at 12, 42, and 48 hours post-operatively between the two groups. 
 
In both groups a decrease in post-operative urinary output was observed. Both 
groups also showed an increase in urea levels, but an increase in creatinine levels 
could only be found in group 1. Ascione and colleagues (2001) reported that 
although off-pump CABG surgery minimizes renal injury, surgical manipulation can 
cause a definite degree of post-operative renal dysfunction. 
 
5.6.4  Post-operative Outcomes and Complications 
 
No major post-operative differences could be demonstrated between the two 
groups.  The only notable difference between the two groups was recorded for the 
ventilation time. Group 2 demonstrated longer post-operative ventilation times 
(median group 2 = 12.00 versus median group 1 = 9.00). 
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  5.7 GENERAL DISCUSSION 
 
Whether or not off-pump surgery is better than on-pump surgery is widely debatable. 
Although some differences were found during on- and off-pump surgery, there were 
no significant differences regarding post-operative outcomes and complication 
between the two groups. 
 
No neurological impairment took place in any of the patients, which can be due to 
the small amount of time spent under the curve (decrease 20% from baseline or 
values below 50) due to interventions by the perfusionist and anaesthesiologist. If no 
corrective action was taken to restore decrease NIRS values the time spend under 
the curve could have been calculated using Slater's formula (Slater et al., 2009). 
 
rSO2 score = 50%; rSO2 - current rSO2 (%) x time (seconds) 
 
The rSO2 score generated is an area under the curve measurement, which accounts 
for both depth and duration of desaturation below the 50% saturation threshold. 
However, in this study the researcher did notice that NIRS could be associated with 
early tubular kidney function impairment in CABG surgery, which led to the polyuric 
phase. Cerebral NIRS should be further investigated as a marker for more than just 
cerebral microcirculation. 
 
MMSE didn’t show any differences between the two groups. A decline in the MMSE 
scores were reported for the patients that fell in group 2 who had compromised 
cerebral oxygenation. To state that these patients had mild cognitive impairment as 
indicated by the criteria published by Lopez et al., (2005) is debatable.  The data 
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was compromised due to several factors: (a) the number of participants in some of 
these groups were limited to only 3 patients (b) the assessments were made by 
multiple perfusionists who were not neurologists or occupational therapists that lack 
interview and interpretation skills (c) a complete battery of neurocognitive tests were 
not administered, only MMSE. 
 
Mortality between on- and off-pump groups was not significant and no patterns 
regarding mortality could be found. Death occurred post-operatively and no NIRS 
monitoring took place after the patients left the operation room. 
 
Cardiopulmonary bypass is associated with post-operative neurological dysfunction 
due to microemboli and hypoperfusion (Edmonds et al., 2004), and although OPCAB 
has become popular over the years, surgical techniques and manipulation of the 
heart can result in compromised cerebral blood flow (Murkin et al., 2000). 
 
Non-pulsatile CPB, inflammatory responses to bypass, hemodilution, and the release 
of free radicals contribute to post-operative renal failure (de Jaegere and Suyker, 
2002). Ascione and co-workers (2001) suggested that OPCAB technique minimizes 
renal injury; anaesthesia and manipulation of the heart may cause a definite degree 
of post-operative renal injury. 
 
Our results indicated that no statistical significant intra-operative events caused a 
decline in cerebral blood flow. In both groups there were patients with minimum 
rSO2 values below 50. In our investigation we did not have a specific algorithm to 
prevent cerebral desaturation or to restore rSO2 levels to normal (rSO2 > 50). In 
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regards to our findings in Analysis 1, there were no differences between on- and off-
pump patients. 
CHAPTER 6: CONCLUSION 
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  6.1 GENERAL 
 
Although the study population was relatively small, the use of cerebral oximetry intra-
operatively, (especially in on-pump cardiac surgery patients), showed a tendency 
towards less renal function impairment in patients with absolute NIRS values > 50 or 
where there was < 20% drop from baseline. However, the absolute values remained 
mostly within the normal range.  It is probably important to consider the time spend 
below 50 or a drop of more than 20%, and to make use of the Slater score to 
determine whether or not the patients were at increase risk for post-operative 
complications (Slater et al., 2007) and with an increased study population, this is 
recommended. 
 
Although Ascione and co-workers (2001) stated that OPCAB is associated with less 
neurological dysfunction and renal insufficiency, this could not be proven by the 
present study. Whether or not OPCAB is better than on-pump CABG surgery is still 
debatable and as this study was underpowered, we cannot draw a definitive 
conclusion from our results. ]\ 
 
The Somanetic INVOS system seems to be an important tool in theatres, and with 
active interventions to keep values > 50 and to prevent a drop of more than 20% 
from baseline, it may improve patient outcomes. It is recommended that 
anaesthesiologists and perfusionists make use of the proposed algorithm presented 
 Chapter 6 
CONCLUSION 
CHAPTER 6: CONCLUSION 
 
 
142 
by Denault and colleagues (2007) (Appendix C) as a guideline to optimalize 
cerebral perfusion and oxygen transfer. 
 
During the research study, fluctuations in NIRS values led to perfusion as well as 
anaesthetic interventions. These interventions limited the periods spend “under the 
curve” and may in itself been a limitation of the study.  
 
In order to elucidate the value of NIRS further, a larger study population will be 
required and a larger absolute number of patients with significant reductions in NIRS 
values for an extended period of time as described by Slater and co-workers (2007). 
 
The role and usefulness of NIRS has been demonstrated in that timely intervention as 
occurred during this observational study, lead to similar clinical outcomes , even in 
the groups of patients that did spent some time, however limited, with impaired NIRS 
values. 
 
The value of routine NIRS monitoring during cardiac surgery has been re-confirmed 
in this study. 
 
6.1.1 LIMITATIONS 
 
1. Observational study design. 
2. Small sample size. 
3. MMSE not done by professional psychiatrist/neurologist. 
4. Insufficient number of patient with extended periods of impaired flow. 
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6.1.2 RECOMMENDATIONS 
 
1. Randomized trial. 
2. Increase study population. 
3. MMSE assessment done by a qualified neurologist/psychiatrist and repeat the 
 test during the 6 week follow-up. 
4. Include additional neuropsychological assessments. 
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EVALUATION OF NEAR-INFRARED SPECTROSCOPY VALUES BETWEEN ON-PUMP AND 
OFF-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH ACUTE 
CORONARY SYNDROME. 
 
          Date: _____________________ 
 
CONSENT TO PARTICIPATE IN RESEARCH 
 
You have been asked to participate in a research study. 
 
You have been informed about the study by ………………………………………. .   
You received an information sheet which is a written summary of the research. 
 
You have been informed about any available compensation or medical treatment 
if injury occurs as a result of study-related procedures.  You may contact Prof FE Smit 
(082 774 1087) and Prof WMJ van Den Heever-Kriek (082 770 5356) at any time if you 
have questions about the research or if you are injured as a result of the research. 
 
You may contact the Secretariat of the Ethics Committee of the Faculty of Health 
Sciences, UFS at telephone number (051) 4052812 if you have questions about your 
rights as a research subject.  Your participation in this research is voluntary, and you 
will not be penalized or lose benefits if you refuse to participate or decide to 
terminate participation. 
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If you agree to participate, you will be given a signed copy of this document. 
 
It has been explained to you, that by participating in this study, there is no additional 
medical risk to you other than those of the intervention which has been discussed 
with you by your Cardiologist or Cardiothoracic Surgeon. 
 
The research study (summarised for you in the information sheet), including the 
above information has also been verbally described to me.  I understand what my 
involvement in the study means and I voluntarily agree to participate.  
 
 
_____________________   __________________ 
Signature of Participant   Date 
 
 
_____________________   __________________ 
Signature of Witness    Date 
(Where applicable) 
 
 
_____________________   __________________ 
Signature of Translator   Date 
(Where applicable) 
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EVALIASIE VAN OXIMETRIE WAARDES TUSSEN OP-POMP EN AF-POMP KORONêRE VAT 
OMLEIDINGS CHIRURGIE IN PATIENTE MET AKUTE KORONêRE SINDROOM. 
        Datum:_______________ 
 
TOESTEMMING TOT DEELNAME AAN NAVORSING 
 
U is versoek om aan ‘n navorsingsstudie deel te neem. 
 
U is oor die studie ingelig deur……………………………………………………….............. 
 
U het ‘n inligtingsdokument wat ‘n geskrewe opsomming van die navorsing is 
ontvang. 
 
U is ingelig oor die moontlike kompensasie en mediese behandeling wat sal intree 
indien komplikasies van u deelname aan die studie intree; 
 
 
U kan Prof FE Smit (082 774 1087 ) / Prof WMJ van Den Heever-Kriek  (082 770 5356) 
enige tyd kontak indien u vrae oor die navorsing het of as gevolg van die navorsing 
beseer is. 
 
U kan die Sekretariaat van die Etiekkomitee van die Fakulteit 
Gesondheidswetenskappe, UV by telefoonnommer (051) 405 2812 kontak indien u 
enige vrae het oor u regte as ‘n proefpersoon. 
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U deelname aan hierdie navorsing is vrywillig, en u sal nie gepenaliseer word of 
voordele verbeur as u weier om deel te neem of besluit om deelname te staak nie. 
 
As u instem om deel te neem, sal ‘n ondertekende kopie van hierdie dokument aan 
u gegee word. 
 
Dit is aan u verduidelik dat u deelname aan hierdie studie, buite die risiko’s van die 
chirurgiese intervensie soos bespreek met u deur u Kardioloog of Kardiotoraks-
chirurg, geen addisionele mediese risiko’s inhou nie. 
 
Die navorsingstudie (opgesom in die inligtingsdokument), insluitende die 
bogenoemde inligting is ook verbaal aan my beskryf.  Ek begryp wat my 
betrokkenheid by die studie beteken.   
 
Ek verstaan ook dat my pasiënt inligting konfidensieel hanteer sal word en dat my 
deelname vrywillig is en ek teen enige tyd kan onttrek. 
 
_____________________________    _____________________ 
Handtekening van deelnemer     Datum 
 
_____________________________    _____________________ 
Getuie       Datum 
(Indien van toepassing) 
 
_____________________________    _____________________ 
Hantekening van Vertaler      Datum 
(Indien van toepassing) 
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Letsatsi: ____________ 
 
TUMELLO YA HO NKA KAROLO DIPATLISISONG 
 
O kopilwe ho nka karolo thutong ya dipatlisiso. 
 
O ile wa tsebiswa ka thuto ena ke 
………………………………………………………………….. 
 
O ka nna wa ikopanya le Prof FE Smit (082 774 1087 ) / Prof WMJ van Den Heever-
Kriek  (082 770 5356) nako e nngwe le e nngwe ebang o nale dipotso mabapi le 
dipatlisiso kapa ebang o ka tswa kotsi ka baka la dipatlisiso. 
 
O ka nna wa ikopanya le Mongodi wa Ethics Committee ya Faculty of Health 
Sciences, UFS nomorong ya mohala ya (051) 4052812 ebang o nale dipotso ka 
ditokelo tsa hao jwaloka eo ho etswang dipatlisiso ka yena. 
 
Ho nka karolo ha hao dipatlisisong tsena ke boithaopong ba hao, mme o keke wa 
fumantshwa kotlo kapa wa lahlehelwa ke menyetla ya hao ebang o ka hana kapa 
wa nka qeto ya ho kgaotsa ka ho nka karolo. 
 
Ha o dumela ho nka karolo, o tla nehwa khopi e saennweng ya tokomane ena 
hammoho le leqhephe la ba nkang karolo e leng le ngotsweng kgutsufatso ya 
dipatlisiso. 
 
Thuto ya dipatlisiso ho kenyellwa lesedi le ngotsweng ka hodimo, di ile tsa hlaloswa 
ho nna ka molomo. 
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Ke utlwisisa hore ho nka karolo ha ka thutong ena ho bolelang.  Ke boetse ke 
utlwisisa hore tlhahiso leseding e mabapi le dintlha tse amang botho ba ka, e tla 
nkwa e le sephiri le hore ho nka karolo ha ka ke boithaopo le hore nka nna ka ikgula 
nako e nngwe le e nngwe. 
 
 
 
____________________     __________________ 
Tshaeno ya motho ya      Letsatsinkang karolo 
 
_____________________     __________________ 
Tshaeno ya mofetoledi     Letsats 
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EVALUATION OF NEAR-INFRARED SPECTROSCOPY VALUES BETWEEN ON-PUMP AND OFF-PUMP 
CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH ACUTE CORONARY SYNDROME. 
 
Dear Patient 
 
We, the department of Cardiothoracic Surgery and Cardiology, are doing research on 
endothelial function as a predictor of post intervention outcomes.  Research is just the 
process to learn the answer to a question.  In this study we want to learn if there is a 
difference in outcomes in patients presenting with acute coronary syndrome and those with 
worsening or chronic stable angina? 
 
Invitation to participate 
 
 We are asking/inviting you to participate in a research study.  If you grant us permission you 
have to sign an informed consent form so that we have evidence that you were willing to 
participate in the research project. 
 
What is involved in the study 
 
This is an uncontrolled longitudinal study.  Sixty patient with acute coronary syndrome (ACS) 
will be recruited from the Cardiology clinic for participation.  This study will commence on the 
18th of June 2007 and is expected to continue until the 31st of July 2008.  Due to the fact that 
every test performed except the oximetry and atherosclerotic measurements is routine 
practice for a patient with ACS the patient won’t be subjected to numerous amounts of 
tests. 
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The following tests will be performed: 
 
A) Physical Examination 
 
After a confirmed diagnosis of acute coronary syndrome and granted consent a complete 
medical history and physical examination will be performed by a qualified medical doctor 
located at cardiothoracic surgery.  (Routine practice for ACS). 
 
B) Cardiology evaluation 
 
The patient will be submitted for a cardiac echocardioFigure and an angiogram at the 
catheter lab on the second floor, Universitas Hospital.  (Routine practice for ACS). 
 
C) Oximetry measurements 
 
The oximetry measurements are non-invasive measurements of regional oxygen saturation in 
the blood.  These measurements will be taken either in the catheter lab or in theatre during 
the surgical procedures and the patients will therefore not experience any discomfort.  
SomaSensors (small round stickers) will be placed on the forehead and on the back of the 
patient to detect the oxygen saturation.  The SomaSensors is linked to an electronic machine 
which will register the readings. 
 
D) Mini-Mental state examination (MMSE) 
 
This is a very brief 30 point questionnaire test that will be used to assess cognition.  Ms Lindy 
Liebenberg will conduct this test before and after the intervention procedures and it will take 
about 10 minutes. 
 
Risks 
 
The research project is very safe.  All the procedures are non-invasive and no adverse effects 
are predicted.  Patients participating in this study will be well monitored and can at any time 
discontinue participation in the study.  The study will be discontinued prematurely if the 
researcher or any of the study leaders feels that a patient’s confidentiality might be 
breached or if any unethical procedures occur. 
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Benefits 
 
We know that SIRS mediators are activated in the endothelium and that this response can be 
abnormal in atherosclerosis.  It is also known that medical treatment with statins and ACE 
inhibitors modifies this response and can improve or normalise endothelial function. SIRS 
occurs more often post –intervention in some patients (e.g. metabolic syndrome, patients 
with pre-op elevated TNF, microalbuminuria). Outcomes in inflammatory markers and clinical 
SIRS might differ between on-pump  and off-pump CABG. 
 
If we can correlate the pre-intervention endothelial function to outcomes in two different 
settings (stable angina and acute coronary syndrome) we might be able to develop a 
rational approach to intervention and choice of intervention. 
 
Your participation will enable us to attempt to try and identify a relationship between clinical 
data, blood tests and endothelial function/atherosclerosis load will be made. 
 
Participation is voluntary 
 
Refusal to participate will involve no penalty or loss of benefits to which the subject is 
otherwise entitled; the subject may discontinue participation at any time without penalty or 
loss of benefits to which the subject is otherwise entitled.  
 
Confidentiality 
 
Efforts will be made to keep personal information confidential.  Absolute confidentiality 
cannot be guaranteed.  Personal information may be disclosed if required by law.  
Organizations that may inspect and/or copy your research records for quality assurance and 
data analysis include groups such as the Ethics Committee for Medical Research and the 
Medicines Control Council. 
 
If results are published, this may lead to individual/cohort identification.  
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Contact details of researcher(s) – for further information/reporting of study-related adverse 
events. 
 
a) Prof FE Smit 
 Head:  Department Cardiothoracic Surgery 
 UFS 
 Cell: 082 774 1087 
 
b) Prof WMJ van den Heever-Kriek 
 Associate Professor 
 CUT 
 Cell: 082 770 5356 
 
Contact details of REC Secretariat and Chair – for reporting of complaints/problems. 
 
a) Prof BB Hoek 
 Chairman:  Ethical Committee 
 UFS 
 Phone:  051 405 3177 
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INLIGTINGSDOKUMENT 
 
EVALIASIE VAN OXIMETRIE WAARDES TUSSEN OP-POMP EN AF-POMP KORONêRE VAT 
OMLEIDINGS CHIRURGIE IN PATIENTE MET AKUTE KORONêRE SINDROOM. 
 
Beste Pasiënt 
 
Ons, die Departement Kardiotorakschirurgie, is besig om navorsing oor endoteel funksie as ‘n 
voorspeller van post intervensie uitkomste in koronêre siekte te doen.  Navorsing is slegs die 
proses waardeur die antwoord op ‘n vraagstuk verkry word.  In hierdie studie wil ons leer of 
daar `n verskil is in die uitkomste van pasiënte wat presenteer met akute koronêre sindroom 
en die met verskwakkende of chroniese stabiele angina? 
 
Uitnodiging om deel te neem 
 
Ons versoek/nooi u uit om aan die navorsingstudie deel te neem.  Indien u aan ons 
toestemming verleen moet u `n toestemmingsvorm teken sodat ons `n bewys het dat u 
gewillig was om aan die studie deel te neem. 
 
Wat behels die studie 
 
Hierdie in `n ongekontrolleerde longitudinale studie.  Sestig pasiënte met akute koronêre 
sindroom (AKS) sal gewerf word vanaf die Kardiologie kliniek vir deelname aan die studie.  
Hierdie studie sal begin op die 18de Junie 2007 en word verwag om voort te gaan tot op die 
31ste Julie 2008.  Al die toeste wat gedoen word, behalwe vir die aterosklerotiese evaluasie 
en oksimetrie lesings, is roetiene toetse vir `n pasiënte met AKS.  Die pasiënt sal dus nie 
onderworpe wees aan groot hoeveelhede toetse nie. 
 
Die volgende toetse sal uitgevoer word: 
 
A) Fisiese ondersoek 
 
Nadat `n bevestigde diagnose van akute koronêre sindroom en toestemming van die die 
pasiënt sal `n volledige mediese geskiedenis en fisiese ondersoek gedoen word deur `n 
gekwalifiseerde mediese dokter by kardiotorakschirurgie.  (Roetiene prakryk vir AKS). 
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B) Kardiologie evaluasie 
 
`n Kardiale echokardiogram en angiogram sal van die pasiënt geneem word in die kateter 
lab op die tweede vloer in Universitas Hospitaal.  (Roetiene prakryk vir AKS). 
 
C) Oksimetrie metings 
 
Die oksimetrie metings is nie-indringende metings van suurstof saturasie in die bloed.    
Hierdie meetings sal in die kateter laboratorium of in die teater gedurende die chirurgiese 
prosedures geneem word en die pasiënt sal dus geen ongerief/ongemak ervaar nie.  
SomaSensors (klein ronde plakkertjies) word of die voorkop en die rug van die pasiënt geplak 
om die suurstof saturasievlakke te meet.  Hierdie plakkers is gekoppel aan ‘n elektronies 
masjien wat die lesings registreer.   
 
D) Kognitiewe toestand evalueringstoets 
 
Hierdie is a vinnige 30-punt vraelys wat gebruik gaan word om kognitiewe funksie te 
evalueer.  Me Lindy Liebenberg sal hierdie toets uitvoer voor en na die intervensie en dit sal 
slegs ongeveer 10 minute neem. 
 
Risiko’s  
 
Hierdie projek is baie veilig.  Al die prosedures is nie-indringend en geen nadelige gevolge 
word voorspel nie.  Pasiënte wat aan die studie deelneem sal gemonitor word en kan enige 
tyd onttrek vanuit die studie.  Die studie sal onmiddellik gestaak word indien die navorser of 
enige ander studieleier voel dat `n pasiënt se konfidensialiteit gebreek word of enige 
onetiese gebeurtenisse plaasvind. 
 
Voordele 
 
Ons weet dat SIRS middellaars geaktiveer word in die endoteel en dat hierdie respons 
abnormaal kan wees met aterosklerose.  Dit is ook bekend dat mediese behandeling met 
statiene en ACE inhibitors hierdie respons verander en dat dit endoteel funksie kan verbeter 
of normaliseer.  In sommige pasiënte vind SIRS meestal post-intervensie plaas (bv.  
metaboliese sindroom, pasiënte met pre-operatiewe verhoogde TNF en mikroalbumienurie 
waardes).  Die kliniese uitkomste van SIRS gebasseer op inflammatoriese merkers mag verskil 
tussen KVO (met gebruik van die hart-long apparaat en daarsonder) en perkutane koronêre 
ingreep.  Indien `n korrelasie tussen pre-intervensie endoteel funksie en uitkomste in twee 
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verskillende gevalle (stabiele angina en akute koronêre sindroom) getref kan word, kan dit 
ons instaat stel om `n rasionale benadering tot intervensie en keuse van intervensie te maak.   
 
U deelname sal ons instaat stel om te poog om die verhouding tussen kliniese data, 
bloedtoetse en endoteel funksie/aterosklerose lading te identifiseer. 
 
Deelname is vrywillig 
 
Weiering om deel te neem sal geen boete of verlies van voordele waarop die deelnemer 
andersins geregtig is behels nie; die proefpersoon kan te eniger tyd aan deelname onttrek 
sonder boete of verlies van voordele waarop die proefpersoon andersins geregtig is. 
 
Vertroulikheid 
 
Daar sal gepoog word om persoonlike inligting vertroulik te hou.  Volkome vertroulikheid kan 
nie gewaarborg word nie.  Persoonlike inligting kan bekend gemaak word as die wet dit 
vereis.  Organisasies wat u navorsingsrekords mag ondersoek en/of kopieer vir 
kwaliteitsversekering en data-analise sluit groepe soos die Etiekkomitee vir Mediese Navorsing 
en die Medisynebeheerraad in.  As resultate gepubliseer word kan dit lei tot 
individuele/groepsidentifikasie. 
 
Kontakbesonderhede van navorser(s)  
Vir verdere inligting/rapportering van studieverwante newe-effekte. 
 
a) Prof FE Smit 
 Hoof:  Departement Kardiotorakschirurgie 
 UV 
 Sel: 082 774 1087 
 
 
b) Prof WMJ van den Heever-Kriek 
 Mede-Professor 
 SUT 
 Sel: 082 770 5356 
 
 
 
 
APPENDIX B 
 
 
Lindy Liebenberg 
173 
Kontakbesonderhede van REC Voorsitter 
Vir raportering van klagtes/probleme 
 
a) Prof BB Hoek 
 Voorsitter:  Etiek komitee 
 UV 
 Telefoon: 051 405 317 
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  PROPOSED CLINICAL ALGORITHM FOR NIRS 
 
Declining cerebral oximeter values, regarding decreased Cerebral oximetry 
during CPB, occurs frequently in cardiac surgery and reflect the changing 
hemodynamic profile of balance between brain oxygen delivery and 
consumption. Since low rSO2 values correlate with adverse neurological 
outcome, continuous assessment via cerebral oximeter, using near-infrared 
spectroscopy, is a valuable patient management tool. Low cerebral oximeter 
values can be corrected with simple interventions (Somanetics 2005). 
 
Step 1 : Mechanical obstruction 
Arterial malperfusion – The first and most important step when rSO2 decrease = 
rule out mechanical obstruction to cerebral blood flow. 
 
Example : Ascending aortic dissection with occlusion in carotid lumen 
                 : Kinking or obstruction, during cerebral perfusion, of the perfusion 
cannula. 
 
Superior Vena Cava obstruction – Cerebral venous obstruction via dislocation of 
heart or venous cannula malposition. 
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CPP (Cerebral Perfusion Pressure) = MAP – jugular venous pressure 
(difference between inflow and outflow pressures) (Denault, 
Deschamps and Murkin, 2007). 
 
Step 2:       Mean Arterial Pressure   
With brain desaturation the most common intervention is to maintain cerebral 
perfusion pressure (CPP) and MAP within 15% of baseline using vasopressors during 
CPB (Denault et al., 2007). 
 
Step 3:  Systemic Oxygenation 
 Presence or absences of peripheral desaturation can be identified by NIRS in 
a variety of clinical settings. 
 Oximetry has been used during CPB to detect vaporizer failure. 
 In such cases, if all else fails, the inspired oxygen fraction would be increased 
during CPB (Denault et al., 2007). 
 
Step 4:  Normal PaCO2 
 Hyperventilation decreases brain oximetry. 
 Hypoventilation increases brain oximetry. 
 PaCO2 – powerful determinant of CBF. 
 Most common causes of  rSO2 : Hyperventilation 
                                                                : Rewarming on CPB 
 When PaCO2 is below 35 mmHg – normalize PaCO2 ≥ 35 mmHg (Denault et 
al., 2007). 
Step 5: Optimize Hemoglobin 
 Hemoglobin (Hb) is the key element of oxygen transfer in the body. 
 Decrease Hemoglobin = Decrease rSO2 
 With onset of CPB, hemodilution causes a decrease in Hb and a decrease in 
MAP due to decrease in viscosity, resulting in a decrease in rSO2. 
 A decrease in rSO2 can be used as an indication for blood transfusion 
(Denault et al., 2007). 
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Step 6: Cardiac Function 
 Decrease cardiac performance = increase in brain oxygen extraction = lower 
oximetry values  
 Increasing your pump flow during CPB is a good technique to correct 
cerebral desaturation (Denault et al., 2007). 
 
Step 7 : Decrease Cerebral Metabolic Rate of Oxygen (CMRO2) 
 Decrease rSO2 = Increase in CMRO2. 
 This may occur after rewarming during CPB. 
 CMRO2 can be reduced through deepening of anaesthesia (Denault et al., 
2007). 
 
Step 8: Other 
 Laminar Flow vs. Pulsatile Perfusion = Laminar flow decreases CBF during CPB, 
therefore during CPB, pulsatile perfusion may be introduced when rSO2 is low. 
Denault and colleagues (2007) have noted that in certain patients there was 
an improvement in rSO2 when pulsatile perfusion was introduced (Denault et 
al., 2007). 
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PROPOSED ALGORITHM IN THE USE OF BRAIN OXIMETRY  
 
 
 
Figure 2.3 Proposed algorithm in the use of Brain Oximetry (CT – computed tomoFigurey; ICHT – 
intracranial hypertension; MAP – mean arterial pressure; MRI – magnetic resonance 
imaging) (Adapted from Denault et al; 2007)   
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